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SUMMARY 
 
 CD38 acts as a bifunctional ectoenzyme, synthesizing (ADP-ribosyl cyclase) and 
degrading (cyclic ADP-ribose (cADPR) hydrolase) cADPR, a calcium mobilizer from 
intracellular pool. CD38 internalization has been proposed as a mechanism by which the 
ectoenzyme produced intracellular cADPR, and thiol compounds have been shown to induce 
internalization.  
 Here, we show the function of ADP-ribosyl cyclase activity may be important for 
its ligand- induced internalization of CD38. Previously, a plasmid construct, pCD38-GFP, 
encoding a fusion protein of CD38-GFP (Green Fluorescent Protein) was generated. Several 
mutants were constructed and cloned into pTRE2-Hyg response plasmid. Their expressions 
were studied in established stable Chinese Hamster Ovary (CHO) Tet-off cells. Wild type 
CD38, C122K, L149V and W162G mutants were expressed on the plasma membrane, but 
the E229G mutant was retained in the cytoplasmic location as revealed via confocal 
microscopy. Mutants (C122K and L149V), which exhibited ADP-ribosyl cyclase activity 
only were able to be expressed on surface membrane and undergo ligand- induced 
internalization. However, the W162G mutant which had shown significant reduction in the 
cyclase activity but with intact hydrolase activity was not able to undergo ligand- induced 
internalization. Glu-229 mutant was shown to be devoid of all its enzymatic activities and 
was neither able to be expressed on surface membrane nor undergo ligand- induced 
internalization.  
 CD38 and its mutants were expressed in CHO Tet-off cells and characterized by 
enzymatic assays, confocal microscopy and immunoblot. We have affinity purified the 
internalized CD38 from NAD+ treated and untreated cell lysates by a streptavidin/ biotin-
  vii 
based method. Altogether, these results demonstrated the important role of ADP-ribosyl 
cyclase activity in ligand-dependent internalization and possible down-stream production of 
intracellular cADPR to mediate calcium signaling.  
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Chapter 1 Introduction  2 
 CD38 or T10 molecule, a membrane glycoprotein of molecular weight of 45-
kDa, was one of the first characterized but least understood human lymphocyte 
differentiation antigen. As most lymphocyte surface markers, it was identified by means 
of monoclonal antibodies. The cDNA encoding the human lymphocyte antigen CD38 was 
isolated and sequenced from a mixture of four different lymphocyte cDNA libraries 
expressed transiently in Cos-7 cells and screened by panning with CD38 monoclonal 
antibodies (Jackson and Bell, 1990). By using antibodies, CD38 was found to have a 
rather unique distribution pattern, being predominantly expressed by progenitors and early 
hematopoietic cells, then lost during maturation, only to be re-expressed during cell 
activation. Because of this curious pattern of expression, CD38 has been used primarily as 
a phenotypic marker of differentiation in normal and leukemic blood cells. However, 
interest in CD38 antigen beyond its use as a marker of cellular differentiation has grown 
recently after a report that human CD38 has significant amino acid sequence similarity to 
ADP-ribosyl cyclase (States et al., 1992), a 29 kDa cytosolic enzyme previously isolated 
from a sea molluse, Aplysia califonica (Hellmich and Strumwasser, 1991; Lee and 
Aarhus, 1991).    
 However, it is no longer just considered a cellular marker for lymphocyte 
differentiation but this exclusive bi- functional ectoenzyme bears complex catalytic 
properties, displaying an ADP-ribosyl cyclase and a cyclic ADP-ribose (cADPR) 
hydrolase that catalyzes the synthesis from the metabolite nicotinamide adenine 
dinucleotide (NAD+) and the hydrolysis of cADPR, respectively. CD38 proteins were 
detected in humans, mice and rats (Reinherz et al., 1980; Howard et al., 1993; Koguma et 
al., 1994).  
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1.1 General Introduction of CD38  
1.1.1 Structure of CD38  
 CD38 is a type II transmembrane glycoprotein of 300 amino acids expressed in 
many vertebrate cells. The deduced amino acid sequences of CD38 have shown that the 
polypeptide consists of three domains, a short NH2-terminal cytoplasmic tail, a single 
transmembrane region, and a large extracellular COOH-terminal catalytic domain (Figure 
1.1). It is a bifunctional ectoenzyme that catalyzes both the synthesis of cyclic ADP-ribose 
(cADPR) from NAD+ and the degradation of cADPR to ADP-ribose by means of its ADP-
ribosyl cyclase and cADPR-hydrolase activities, respectively (De Flora et al., 1997).     
 The gene encoding human CD38 protein is located on chromosome 4p15 
(Nakagawara et al., 1995). The short cytoplasmic domain of CD38 contains no known 
motifs (Src homology domain 2 or 3 [SH2 or SH3], antigen receptor activation motif 
[ARAM], or pleckstrin homology [PH]) that could mediate interactions with other 
signaling proteins and seems to have no enzymatic activity. The intracellular part of CD38 
contains two conserved serine residues within the consensus sites recognized by cyclic 
guanosine monophosphate (cGMP)-dependent protein kinases. cGMP - dependent serine/ 
threonine kinases in sea urchin eggs modulate the activity of ADP-ribosyl cyclase, an 
enzyme that displays a functional homology to CD38 protein (Lund et al., 1996). Four 
potential amino-terminal linked glycosylation sites and two to four high-mannose amino-
terminal linked oligosaccharide chain containing sialic acid residues contribute 25% of the 
molecular mass of the CD38 protein. Extracellular part of CD38 may function in 
attachment to the extracellular matrix. Human CD38 proteins contain three putative 
hyaluronate-binding motifs (HA motifs), two of which are located in extracellular domain  
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and one in the cytoplasmic part of the molecule (Nishina et al., 1994). In addition, four 
asparagines residues in the extracellular part of CD38 serve as potential carbohydrate-
binding sites.  
 The human CD38 molecule contains 12 conserved cysteines, 11 of which are 
located in the extracellular domain. It has been shown previously that four cysteines (Cys-
119, Cys-160, Cys-173, and Cys-201) play an essential role in the cADPR synthetic and 
cADPR hydrolytic activity of human CD38 (Tohgo et al., 1994). Furthermore, the C- 
terminal part of CD38, including the peptide sequence of residues 273-285 and in 
particularly Cys-275, contributes to the NAD glycohydrolytic activity of CD38 (Hoshino 
et.al, 1997). In particular, the conserved pair of amino acids Glu-146 and Asp-147 seems 
to endow ADP-ribosyl cyclase activity to the CD38 protein (Grimaldi et al., 1995; 
Okazaki and Moss, 1996). Reducing agents such as dithiothreitol, 2-mercaptoethanol, or 
reducing glutathione inhibit the enzymatic activity of CD38, suggesting that the disulfide 
bonds are important for the catalytic activity of the CD38 proteins (Tohgo et al., Zocchi et 
al., 1995). A number of leucines within the transmembrane and extracellular domains 
potentially form leucine zippers motifs that can provide associations of CD38 with other 
proteins (Hurst, 1994).  
 The dileucine motifs in the CD38 molecule is, however, not accessible to the 
intracellular targeting because of the extracellular location. Two dileucine (LL) motifs are 
located in the middle of human CD38 proteins. Intracellular targeting and internalization 
of different transmembrane proteins require the LL motif within the C terminus of the 
cytoplasmic domains (Aiken et al., 1994). Binding of NADP+ at the active site of CD38 
can facilitate the assembly of these putative leucine zippers for mutual interactions 
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between CD38 molecules on the membrane that in turn can lead to lateral movements and 
clustering of CD38 and followed by internalization.   
 In addition to the membrane-anchored form (mCD38; 45KDa), a soluble form 
of CD38 also exists (sCD38; 39KDa), probably as a result of enzymatic cleavage of the 
cell-surface protein. Therefore, the soluble form of CD38 can be detected in vitro in 
culture supernatants from alloactivated T- lymphocytes and CD38+ tumor cell lines. It is 
also detectable in normal amniotic fluid and in serum and ascites from patients with 
multiple myeloma (Funaro et al., 1995). Not long ago, a high molecular mass of CD38 
(190kDa) was identified in the retinoic acid (RA)- induced human myeloid leukemia cells 
(Umar et al., 1996). This high molecular weight form may be the result of 
transglutaminase-catalyzed post-translational cross- linking of mCD38. A CD38-like 
78kDa soluble protein was also identified in culture supernatants of Epstein-Barr virus 
(EBV)-transformed B cells from patients with X-linked agammaglobulinemia (XLA) 
(Mallone et al., 1998). The behavior of sCD38 appears to be similar to that of many other 
receptors enzymatically cleaved from leukocyte membranes in response to interaction 
with ligands or agonistic antibodies which mimic the natural ligands (Higuchi and 
Arrgarwal, 1994; Bazil and Horejsi, 1992; Berg and James, 1990). 
  
1.1.2 Tissues distribution of CD38 
 Although CD38 was initially discovered as a differentiation marker of T-
lymphocytes (T10), it is now clear that various levels of CD38 can be discovered in a 
large number of cells and tissues. Thus, CD38 has been found on neurons of human brain 
(Mizuguchi et al., 1995), pancreatic cells (Kato et al., 1995), epithelial cells of the prostate 
(Kramer et al., 1995), and other cells (Mehta et al., 1996).  Studies of the expression of 
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CD38 have been a focus of recent research; the results obtained suggest that the molecule 
is widely distributed. An interesting observation is that the surface expression of human 
CD38 varies significantly with age. In adults, the expression of CD38 protein is present on 
the majority of natural killer cells, T cells, B cells, monocytes/macrophages (Malavasi et 
al., 1994), and to some extent on platelets (Ramaschi et al., 1996) and erythrocytes 
(Zocchi et al., 1993). Furthermore, high glucose-utilizing tissues such as the pancreas, 
brain, spleen and liver express high amounts of CD38 (Koguma et al., 1994). CD38 plays 
a particularly central role in glucose- induced insulin secretion from islet cells in the 
pancreas.   
 In mouse, CD38 is also expressed by a significant portion of T- lineage cells, 
natural killer cells and myeloid cells. T lymphocytes and myeloid cells do express variable 
amounts of surface CD38, but its expression was never as high as in the human 
counterparts (Lund et al., 1995). The difference in expression between species can be 
explained by assuming that the murine CD38 belongs to the CD38 family but is not the 
exact orthologue of the human antigen.  
 However in rat, the information available is very limited and does not allow 
comparison with human or mouse molecule. Despite that, the mRNA for CD38 has been 
detected in various rat tissues, namely, in the liver, heart, thymus, thyroid gland, adrenal 
gland and pancreatic islets (Koguma et al., 1994).  
 A new CD38-like molecules, CD157 (BST-1/BP-3) has been discovered, and 
appears to be a cell surface molecule. Two groups have isolated the human [bone marrow 
stromal cell antigen 1 (BST-1)] and mouse (BP-3) analogs of a 
glycosylphosphatidylinositol (GPI)-anchored membrane protein that is expressed by an 
array of hematopoietic and non-hematopoietic cells. These proteins bear the same 
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structural relationship to Aplysia ADP-ribosyl cyclase that is exhibited by CD38 (Table 
1.1).   
 
1.2 CD38 as an Enzyme 
1.2.1 Enzymatic activities of CD38 
 The first evidence for the enzymatic activity of CD38 was reported in the 
murine model in 1993 (Howard et al., 1993) and later was confirmed in humans (Gelman 
et al., 1993). CD38 is one of the first few cell surface signaling molecules shown to 
possess ectoenzymatic activity. It is a bifunctional ectoenzyme that catalyzes both the 
synthesis of cyclic ADP-ribose (cADPR) from NAD+ and the degradation of cADPR to 
ADP-ribose by means of its ADP-ribosyl cyclase and cADPR-hydrolase activities, 
respectively (De Flora et al., 1997) (Figure 1.2). The overall catalytic activity of CD38 is 
similar to that of NAD+ glycohydrolase (NADase). NADases are a diverse group of 
enzymes that have been grouped together because of their common activity; they cleave 
the nicotinamide-ribose bond of NAD+ to adenosine diphosphoribose (ADPR) and 
nicotinamide. To distinguish the Aplysia enzyme from the conventional NADases that 
produce ADP-ribose, the name Aplysia ADP-ribosyl cyclase was proposed (Lee and 
Aarhus, 1991).  
 Aplysia Californica ADP-ribosyl cyclase has been found to share considerable 
structural homology with the mouse and human CD38 (States et al., 1992). In addition to 
ADP-ribosyl cyclase activity, purified CD38 also exhibited the ability to hydrolyze 
cADPR to ADPR (Howard et al., 1993). The overall reaction thus catalyzed by CD38 is 
the conversion of NAD+ to ADPR and nicotinamide, a reaction identical to that catalyzed 
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by NAD-glycohydrolase (NADase). CD38 can also utilize nicotinamide guanine 
dinucleotide (NGD) and nicotinamide adenine dinucleotide phosphate (NADP+) as 
substrates, leading to the synthesis of cyclic GDP-ribose (cGDPR) and nicotinic acid 
adenine dinucleotide phosphate (NAADP+), respectively. The Ca2+ release mechanism 
activated by NAADP is totally independent of cADPR and inositol trisphosphate (IP3) 
(Albrieux et al., 1998). 
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CD38 in humans 
 Lymph node Lymphoblast germinal cells, plasma cells and interfollicular cells  
 Thymus Paracortical and mainly medullary thymocytes 
 Brain Perikaryal and dendritic cytoplasm of neurons 
 Digestive tract Lamina propria lymphocytes 
 Kidney Proximal tubuli 
 Prostate Cytoplasmic membrane and secretory vacuoles 
 Skeletal and cardiac muscles Sarcolemmin of myocites and cardiomyocites 
 
CD38 in mouse 
 Lymphocytes Predominantly B cells and cell lines; variable proportions of T cells   
  and thymocytes  
Myeloid cells  Variable proportions: MAC-1 macrophages from peritoneum are  
CD38+, unstimulated BM macrophages are CD38-; BM-derived cell 
lines in GM -CSF and CD38+ 
 
CD157 (BST-1/BP-3) in human and mouse 
B lymphocytes 100% pre-B in BM; 35% circulating B;30% splenocytes; < 20% in 
lymph node, peritoneum and Beyer’s patches 
Myeloid cells  Almost absent in BM; relatively high in circulating nutrophilis and 
peritoneal macrophages   
 Vessels  Constitutive in endothelial cells and not enhanced by IL-1 
 Stroma and synovia Cell lines constitutively expressing high levels  
 Epithelial cells  Bowel’s brush border, collecting tubules of the kidney 






































 Figure 1.2 Enzymatic pathways involved in the metabolism of  Cyclic ADP-
ribose. CD38 is a lymphocyte antigen that is also a bifunctional enzyme, 
catalyzing both the synthesis and the hydrolysis of cyclic ADP-ribose. 
 
 Reproduce from Lee et al (1994), Vitamin & Hormones, Vol 48: 199-257 
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1.2.2 Cyclic ADP-ribose 
 cADPR is a naturally occurring metabolite of NAD+, which is involved in Ca2+ 
signaling (Lee et al.,1995). There is a growing recognition that it is an endogenous 
modulator of cADPR-sensitive Ca2+ release mechanism (Lee et al., 1996). Ca2+ release by 
cADPR was discovered in sea urchin eggs in 1987 (Clapper et al., 1987). cADPR 
possesses many characteristics of a novel second messenger acting on a ryanodine-
sensitive Ca2+ release channel distinct from that mediated by inositol trisphosphate (IP3) 
receptors. cADPR, a known endogenous modulator of ryanodine receptor Ca2+ releasing 
channels, is also found in the nervous system.  FK506, an immunosuppressant that 
prolongs allograft survival, as well as cADPR, were found to induce the release of Ca2+ 
from islet microsome (Okamoto et al., 1999). In cells, Ca2+ -induced- Ca2+ -release 
(CICR) mechanism requires calmodulin and Ca2+. Ca2+ release is also induced by the 
CICR modulators, ryanodine and caffeine. The discovery of sensitizing effects of cADPR 
on Ca2+ release provides a physiological mechanism for modulating its Ca2+ sensitivity 
over a wide range. The cyclic nucleotide is synthesized from NAD+ by ADP-ribosyl 
cyclase (ADPR cyclase) and is degraded by cADPR hydrolase to ADP-ribose. The 
enzymes involved in the metabolism of cADPR are summarized in Figure 1.2. 
 Walseth and Lee (1993) have described several 8-subsituted analogs of cADPR 
that antagonize the actions of cADPR. 8-Amino-, 8-Bromo-, and 8-Azido-derivatives of 
cADPR were synthesized by incubating the appropriately substituted NAD+ analogs with 
the purified ADP-ribosyl cyclase from Aplysia ovotestis. Studies using these analogs 
indicate that the 8-position of cADPR is critically important for its Ca2+ - releasing 
activity, since none of the analogs had the ability to release Ca2+ from sea urchin egg 
microsomes. However, all three block cADPR from releasing Ca2+; 8-Amino-cADPR is 
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the most effective. The antagonistic effects of these cADPR analogs are competitive since 
high concentrations of cADPR can overcome the inhibition, suggesting that the analogs 
may bind to the same site as cADPR itself.  
 
1.2.3 Other known enzymatic activities of CD38     
 Besides generating cyclic ADP ribose and ADP ribose, CD38 may also 
function as a mono-ADP-ribosyl transferase. One group (Grimaldi et al., 1995) has 
shown that  recombinant murine CD38 exhibits autoribosylation and was able to 
ribosylate a number of different proteins at the cysteine residue. Another group (Okazaki 
and Moss, 1996) has observed that CD38 and CD38-related proteins shared similar 
catalytic amino acid sequences to that found in eukaryotic mono-ADP-ribosyl transferases 
and in bacterial toxin transferases.    
 
 
1.3 Regulation of CD38 function 
 Various chemical agents do affect the enzymatic activity of CD38. The cyclase 
activity of CD38 from human erythrocyte membranes was found  to be stimulated by Cu2+ 
and Zn2+ (Zocchi et al., 1993). Besides, Zn2+ ion has also been shown to stimulate the 
ADP-ribosyl cyclase activity of recombinant CD38, while dramatically inhibited the NAD 
glycohydrolase activity of CD38 (Kukimoto et al., 1996). Gangliosides inhibited 
glycohydrolase and ADP-ribosyl cyclase activity of CD38 (Yokoyama et al., 1996). ATP 
has been shown to inhibit cADPR hydrolase of human CD38 but the ADP-ribosyl cyclase 
activity was unaffected, leading to preferential accumulation of cADPR (Takasawa et al., 
1993).  
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 The expression of CD38 in hematopoietic cells (Drach et al., 1994) was 
increased by all-trans-retinoic acid (ATRA). After the synthesis, CD38 undergo 
posttranslational modification into a higher molecular mass form (190kDa). 
Monodansylcadaverine, a specific substrate inhibitor of trans-glutaminase, inhibits the 
oligomerization of CD38 into a high-molecular-weight form in ATRA-treated HL-60 
cells, suggesting that CD38 is cross- linked through a trans-glutaminase reaction (Umar et 
al., 1996). Besides, all trans-retinoic acid, 1,25-dihydroxyvitamin D3 also regulate the 
induction of CD38 expression in certain hematopoietic cells (Galibert et al., 1996). It has 
been shown by another group, (Stoeckler et al., 1996), that in vitro exposure of CD38 to 
1,25-dihydroxyvitamin D3 increased CD38 density on activated tonsillar B cells and 
peripheral T cells. Furthermore, Interleukin-4 has been found to mediate transcriptional 
down-regulation of CD38 expression in B cells by a serine/threonine kinase-dependent 
mechanism (Shubinsky et al., 1996). 
 
1.3.1 Topological paradox of CD38 
  The enzymatic activities of CD38 are displayed by the extracellular domain. 
Despite the ectoenzyme nature of CD38, significant levels of cADPR were still observed 
in CD38+ cells (Takahashi et al., 1995). The unusual properties of CD38/cADPR system 
and the many still unanswered questions on its function are potential questions for future 
research to be carried out. Internalization of membrane CD38 might be a solution to the 
topological paradox. The apparent topological paradox (Figure 1.3) of ectocellular 
synthesis and intracellular activity of cADPR might be explained: (a) influx of cADPR 
across the plasma membrane to reach its target stores, as suggested by experiments on 
cerebellar granule cells; and (b) NAD+ - induced internalization, following membrane 
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oligomerization, of CD38 with consequent partial import of cADPR metabolism to an 
intracellular compartment, as recently observed in lymphoid B cells.  Two different 
processes which this paradox can be overcome were described by two groups: (1) 
Incubation of Namalwa B cells with external NAD+ has been shown to result in an 
extensive internalization of CD38 accompanied by an increase in intracellular ADP-
ribosyl cyclase activity and of intracellular cADPR concentration (Zocchi et al., 1996); (2) 
the cADPR-transporting function of membrane-bound CD38, which behaves as a 
catalytically active transporter responsible for generation and selective influx of cADPR 
across membranes (Franco et al., 1998). 
 
1.4 CD38 as an adhesion molecule 
 The initial clue concerning the involvement of CD38 in cell-cell contacts came 
from distribution studies among cells of lymphatic origin. CD38 is present on the 
membrane of cells for which heterotyp ic interactions are a crucial development step 
(Mehta et al., 1996). The CD38-mediated adhesion is weak, allows lymphocyte rolling 
over HEC monolayers and is overwhelmed by integrin function (Dianzani et al., 1994). 
These features resemble those of selectins, which are responsible for dynamic interactions 
in the bloodstream between leukocytes and endothelial cells. However, CD38 lacks 
structural homologies or sequence similarities to selectins.  
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Figure 1.3 Topological paradox of CD38. CD38-catalyzed extracellular formation of 
cADPR (cADPRE) and intracellular Ca2+-releasing activity of cADPR (cADPRI) on 
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The molecule, Moon-1, a 120-kDa protein was first identified as a natural 
ligand for human CD38 (Deaglio et al., 1996). It was shown to co-expressed with CD38 
on vascular endothelium, lymphocytes, platelets, NK cells, T, B and myeloid cells. Thus 
CD38 may be involved in the homotypic and heterotypic adhesiveness of lymphocytes 
and in the cooperative interactions. Further studies have shown that the molecule 
recognized by Moon-1 mAb was found to be CD31, which is a 130KDa member of the 
immunoglobulin (Ig) superfamily (Deaglio et al., 1998). Another aspect which has 
received attention is the novel intracellular signaling pathway initiated by CD38/CD31 
binding. They share the ability to transduce extracellular signals, resulting in an increase 
of cytoplasmic Ca2+ levels through IP3-dependent mechanisms. In addition, CD38/CD31 
interaction plays a role in cytotoxicity. The results indicate that CD38 and CD31 are 
almost constantly always co-expressed on the surface of the IL-2-dependent T cell line 
TALL-104 (Cesano et al., 1998). Indeed, CD31 ligation dramatically increases 
cytotoxicity, while CD38 induces cytokine synthesis and release. 
 
 
1.5 The CD38 family and its related molecules 
 The identification of structural and catalytic homologies between CD38 
molecule and Aplysia ADP-ribosyl cyclase has lead to the identification of several other 
molecules displaying similar characteristics and sequences as CD38. One other family 
member includes CD157, preciously designated BST-1 or BP-3 antigen by several 
different investigators. This molecule has been recently been characterized as a 
glycosylphosphatidylinositide (GPI)- anchored leukocyte surface protein (Kaisho et al., 
1994; Dong et al., 1994; Itoh et al., 1994; Ishihara et al., 1997). The expression patterns of 
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both molecules are overlapping in several tissues and hematopoietic systems or 
compensating in certain microenvironments, suggesting that CD157 and CD38 are 
functionally cooperating or compensating in distinct situations (Ishihara et al., 1997) 
(Table 1.2).  
1.6 CD38 and diseases 
 CD38 has been of interest clinically because its expression is upregulated on T 
lymphocytes during acute viral infections and other pathological conditions (Akbar et al., 
1993; Callan et al., 1998).  Previous studies (Ellis et al., 1995; Stevenson et al., 1991) 
have found that CD38-specific antibodies is useful in the treatment of leukemia and 
myeloma. Therefore, CD38 was passed from being a simple activation marker to a multi-
functional surface receptor, possessing both complex enzymatic and cell-surface adhesion 
functions. Other reports stem from recent findings concerning its distribution (e.g., 
Alzheimer’s disease) or from its newly attributed functions (e.g., Bruton’s X-linked 
agammaglobulinemia). The other results available in the literature reflect the use of CD38 
molecule as a prognostic marker in several neoplastic diseases.   
1.6.1 Leukemia and myeloma 
 CD38 has been widely used as a marker to study normal T and B cell 
differentiation and also as an auxilium in the systematic classification of lymphocyte 
malignancies. CD38 is highly expressed in leukemia blast cells of most patients with acute 
leukemia. Although detection of CD38 does not play a critical role in modern leukemia 
classification and does not clearly identify subtypes of leukemias with distinctive 
treatment outcomes, the widespread expression of this surface molecule suggests the 
potential use of anti-CD38 antibodies as antileukemic agents.   
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1.6.2 HIV infection 
 More than a decade ago, it was observed that CD8+ T-cells in AIDS patients 
have an increased expression of CD38 (Salazar-Gonzales et al., 1985). It was subsequently 
shown that the expansion of these cells preceded the decline in CD4+ T-cells and the 
development of AIDS (Bofill et al., 1996). This observation was subsequently expanded 
by some researchers who used CD38 as a useful and reliable prognostic marker for the 
pathological development of AIDS (Liu et al., 1998). CD38 expression inhibits 
lymphocyte susceptibility to HIV infection, probably by inhibiting gp120/CD4-dependent 
viral binding to target cells (Savarino et al., 1996). 
 
1.6.3 Alzheimer’s disease 
 The CD38 antigen was detected in the perikaryal and dendritic cytoplasm of 
neurons and also in the neurofibrillary tangles that occur in the neuronal perikarya and 
proximal dendrites that are the pathological hallmark of Alzheimer’s disease (Otsuka et 
al., 1994). The neuronal localization of CD38 perfectly matches the predicted function of 
the molecule, which ultimately leads to the mobilization of intracellular Ca2+ and 
consequently may control certain brain functions such as neuronal plasticity.  
 
1.6.4 X-linked agammaglobulinemia (XLA) 
 Bruton’s disease or XLA is characterized by a reduced concentration of serum 
Ig secondary to a dramatic decrease of circulating B cells (Conley et al., 1992). The gene 
responsible for this disease is Bruton’s tyrosine kinase (Btk), which encodes a protein 
sharing some features with src tyrosine kinase family. It is likely that Btk is an integral 
component of the CD38-induced signal transduction pathway in B cells.   




Molecule Mol. Mass (kDa) Membrane   % Amino acid  Distribution 
    Association  similarity 
 
  
Human CD38 43.7  TM   100   Hemopoietic, other 
Murine CD38 42  TM   70   B,T and NK cells, 
                  monocyte/macrophage 
Rat CD38      34.4  TM   76   Spleen, liver,  
heart,thymus,ileum,  
      colon, salivary gland 
Human BST -1 43  GPI-anchored  33   Stromal, endothelia   
cells 
Murine BP3-BST-1 38-48  GPI-anchored  30   Early B and T 
lymphocytes 
Rat BST -1 32-35  GPI-anchored   33   Kidney, spleen, heart,  
thymus 









Table 1.2 CD38 family and other related molecules 
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1.7 Green Fluorescence Protein 
 Green fluorescent protein (GFP) is a stable and proteolysis-resistant single chain 
of 238 amino acid protein isolated from jellyfish Aequorea victoria (Figure 1.4). It 
maximally absorbs blue light at 395 nm, emits green light with a peak at 509 nm and a high 
quantum yield of 0.72 to 0.85 (Kendall & Badminton, 1998). In A. victoria, light is produced 
when calcium binds to the photoprotein, aequorin. The energy transfer from aequorin to GFP 
results in the emission of green light. Formation of the fluorophore in GFP requires 
molecular oxygen but once formed it absorbs and emits light without cofactors. GFP 
fluorescence can also be detected by ultraviolet light excitation. 
 The most distinctive feature of the fold of GFP is an 11-stranded b  barrel with a 
coaxial helix, with the chromophore forming the central helix (Ormo et al., 1996). Almost all 
the primary sequences are used to build the b-barrel and axial helix, so that there are no 
obvious places where one could design large deletions and reduce the size of the protein. The 
development of GFP mutants with red-shifted excitation and emission maxim would be 
valuable for avoidance of cellular autofluorescence at shorter wavelength and for 
simultaneous multicolour reporting of activity of two or more cellular processes. The protein 
is stable and can be functionally expressed in a wide variety of organisms including 
prokaryotes, plants, mammalian cells, parasites, fungi and yeasts.  
 GFP is used frequently as a reporter of gene expression (Charlfie et al., 1994) and 
protein localization in live cells in real time. The fluorescence is an intrinsic property of the 
protein, which does not require additional gene products, substrates or cofactors and occurs, 
in a species independent fashion. Because fluorescence requires no cofactors, the GFP signal 
can be recorded in living cells with no disruption of cellular integrity.   






Figure 1.4 Green Fluorescent Protein. 238 amino acids make up the green fluorescent 
protein. Strands of -sheet (blue) form the walls of a cylinder. Short segments of -helices (red) 
cap the top and bottom of the 'b-can' and also provide a scaffold for the fluorophore which is 




Reproduce from www.biochem.arizona.edu/dept/ GreenFlour-miesfeld.jpg  
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Besides, the fluorescence signal is highly resistant to photo bleaching and no apparent toxic 
effects of GFP expression in bacteria or eukaryotes.  
 Despite all the advantages mentioned above, GFP also suffers from several 
disadvantages. For example, the signal intensity may be too weak for some applications, 
however brighter GFP mutants can overcome this limitation. Future directions for 
improvement of GFP as a genetic reporter include efforts to increase the intensity of 
fluorescence signal and thereby enhance detection sensitivity, and to reduce the variability of 
signal between replicate samples.  
 
1.8 Tet-Off system 
 In the Tet-Off system, gene expression is turned on when tetracycline (Tc) or 
doxycycline (Dox; a Tc derivative) is removed from the culture medium. Maximal 
expression levels in Tet systems are very high and compare favorably with the maximal 
levels obtainable from strong, constitutive mammalian promoters such as CMV. Unlike other 
inducible mammalian expression systems, gene regulation in the Tet Systems is highly 
specific, so interpretation of results is not complicated by pleiotropic effects or nonspecific 
induction. 
 
1.8.1 Components of Tet-off system 
 The first component of the Tet system is the regulatory protein, based on TetR 
(Tet repressor protein). In the Tet-off system, this protein is a fusion of amino acids of TetR 
and the C-terminal of the Herpes simplex virus VP16 activation domain: The VP16 domain 
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converts the TetR from a transcriptional repressor to a transcriptional activator, and the 
resulting hybrid protein is known as the tetracycline-controlled transactivator (tTA).  
 The second component is the response plasmid (pTRE) which expresses a gene of 
interest (Gene X) under the control of the tetracycline-response element (TRE): The TRE 
consists of seven direct repeats of a 42-bp sequence containing the tetO, and is located just 
upstream of the minimal CMV promoter, which lacks the strong enhancer elements normally 
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Figure 1.5 Tet-off system. The TRE is located upstream of the minimal immediate early 
promoter of cytomegalovirus (PminCMV ), which is silent in the absence of activation. tTA 
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1.8.2 Advantages of Tet-system 
  The Tet-Off and Tet-On systems have several advantages over other regulated 
gene expression systems that function in mammalian cells:  
 (1) The system is under extremely tight on/off regulation. The background, or 
leaky, expression of Gene X in the absence of induction is extremely low.  
 (2) No pleiotropic effects. When introduced into mammalian cells, the prokaryotic 
regulatory proteins (TetR or rTetR) act very specifically on the ir target sequences, 
presumably because these regulatory DNA sequences are nonexistent in eukaryotic genomes 
(Harkin et al.,1999).  
 (3) High inducibility and fast response times. With the Tet Systems, induction can 
be detected within 30 minutes using nontoxic levels of inducer. Induction levels up to 
10,000-fold have been observed. In contrast, other systems for mammalian expression exhibit 
slow induction (up to several days), incomplete induction (compared to repressor- free 
controls), low overall induction (often no more than 100-fold), and high (nearly cytotoxic) 
levels of inducer (reviewed by Gossen et al., 1993; Yarronton, 1992).  
 (4) High absolute expression levels. Maximal expression levels in the Tet systems 
can be higher than expression levels obtained from the CMV promoter or other constitutive 
promoters. For example, Yin et al. (1996) reported that the maximal level of luciferase 
expression in HeLa Tet-Off cells transiently transfected with pTRE-Luc is 35-fold higher 
than that obtained with HeLa cells transiently transfected with a plasmid expressing 
luciferase from the wild-type CMV promoter.  
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 (5) Well-characterized inducer. In contrast to the inducer used in other systems, 
such as in the ecdysone system, Tc and Dox are inexpensive, well characterized, and yield 
highly reproducible results.  
 (6) Activation of a promoter, rather than repression, to control expression. To 
completely shut off transcription, repression-based systems require very high—and difficult 
to attain—levels of repressor to ensure 100% occupancy of the regulatory sites. Even if 
suitably high levels of repressor can be obtained, the presence of high repressor levels makes 
it difficult to achieve rapid, high- level induction (Yao et al.,1998) . For a more complete 
discussion of the advantages of activation versus repression, see Gossen et al. (1993). 
 
1.8.3 Tet-off vs Tet-on 
 Although the Tet-Off system has been studied more extensively than the Tet-On 
system, the two systems are truly complementary. When properly optimized, both systems 
give tight on/off control of gene expression, regulated dose-dependent induction with similar 
kinetics of induction, and high absolute levels of gene expression. Thus, for most purposes, 
there is no inherent advantage of using one system over the other. With the Tet-Off system, it 
is necessary to keep Tc or Dox in the medium to maintain the native (off) state. Because Tc 
and Dox have relatively short half- lives (see below), one must add Tc or Dox to the medium 
at least every 48 hours to suppress expression of Gene X. Conversely, in the Tet-On system, 
the native (off) state is maintained until induction. For this reason, Tet-On may be more 
convenient in transgenic applications, because you need only add Dox to the animals' diet 
when induction is desired.  
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1.9 Objectives of the Study 
 The objective of this study is to determine effect of site-directed mutations on  rat 
CD38 enzyme activity and dynamics in tet-off Chinese Hamster Ovary cells. The rationale 
for this study is CD38 has been found to internalize upon NAD+ ligand-induced, therefore 
from this study we hope to identify the amino acids which is important to induce 
internalization of CD38. The particular emphasis is on the effect of the constructed CD38 
mutants in ligand-dependent internalization of CD38 in mammalian cells. This was 
investigated by using a variety of methods: 
1) Confocal microscopy to view the expression and investigation of wild-type CD38 and 
constructed mutants. 
2) Expressed proteins characterized by Western blot and enzyme assays. 
3) Real time-imaging of ligands induced internalization of CD38.  
4) Quantitation of internalized CD38 using streptavidin-based method. 
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2.1 Materials 
2.1.1 Bacterial strains  
The strain of Escherichia coli (DH5á) used in this study was prepared and 
described in section 2.2.3.1. Long term storage of bacteria was carried out in LB-Broth with 
20% glycerol at -70C.  
 
2.1.2 Mammalian cell line 
 Chinese Hamster Ovary cells (CHO) was obtained from the American Type 
Culture Collection. For long term storage, cells were suspended in storage media (RPMI 
1640 supplemented with 20% Fetal Bovine Serum and 10% DMSO) and kept in liquid 
nitrogen. For short term storage, cells are suspended in the same storage media and kept at -
80C. CHO Tet-off cells were established (see section 2.2.1.4) and stored in the same storage 
media as described. 
   
2.1.3 Plasmids 
 pEGFP-N1 (purchased from Clontech, USA) encodes a red-shifted variant of 
wild-type GFP which has been optimized for brighter fluorescence and higher expression in 
mammalian cells (Excitation maximum = 488 nm; emission maximum = 507 nm.). Genes 
cloned into the MCS will be expressed as fusions to the N-terminus of EGFP if they are in 
the same reading frame as EGFP and there are no intervening stop codons.  
 pTet-off is a regulatory vector for use in Tet- Off system. This consists of a fusion 
of amino acids 1–207 of TetR and the C-terminal 127 amino acids of the Herpes simplex 
virus VP16 activation domain.  
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 pTRE2-hyg is an expression plasmid, which expresses a gene of interest (Gene X) 
under control of the tetracycline-response element, or TRE. 
 
2.1.4 Synthetic primers 
 The primers used for this study were synthesized by GenSet. The sequences and 
usage of these primers were described in relevant chapters. 
 
2.1.5 Media and solutions  
2.1.5.1 Bacterial media 
 All media for bacteria were sterilized by autoclaving at 15 Lb/in2 for 15 min. 
Thermolabile supplements such as antibiotics were filter-sterilized through 0.2 mm filters and 
added to the autoclaved media which have been cooled to 60°C. 
 LB-broth (Luria-Bertani medium): 1.0% Bacto-trypton, 0.5% Yeast-extract                                    
1.0% NaCl. The pH value was adjusted to 7.0 with NaOH prior to autoclaving. 
 LB agar plate: LB-broth + 15 g/L agar. After autoclaving and cooling to 60°C, 
the above medium was poured to 10 cm petri dish. 
 Antibiotics: Ampicillin                                        50 mg/ml 
       Kanamycin                                       25 mg/ml 
The antibiotics were prepared as stock solutions, sterilized by filtration and stored in aliquots 
in –20°C. 
 
2.1.5.2  Media and reagents for mammalian cell culture  
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 Incomplete RPMI 1640 medium was purchased from the NUMI store (National 
University of Singapore Medical Institute) store. Before use, add Penicillin/Streptomycin of 
50 u/50 mg per ml, 10% FBS (sterile fetal bovine serum, inactivated) was added. For the 
preparation of Tet-off media for CHO Tet-off cell line, the same approach as the above was 
used except Tet System Approved Fetal Bovine Serum was used in the place of FCS.  
 Antibiotics: G418 (50 mg/ml). G418 was prepared as stock solutions, sterilized 
by filtration and stored in aliquots at –20°C. 
 Mammalian cell freezing medium: Complete RPMI-1640 medium was used to 
prepare mammalian cell freezing media, consisting of 60 % complete RPMI-1640 medium, 
30% of FBS and 10% DMSO (Dimethyl Sulfoxide).  
      
2.1.5.3 Supplier for reagents and other materials 
 Standard analytical grade laboratory chemicals for the preparation of general 
reagents were obtained from Sigma, Merck and Clontech. Special reagents were obtained 
from:  
 Amersham Pharmacia Biotech, USA 
 ECL TM Western blotting detection reagents    
 Hyperfilm ECL. 
  
 Bio-Rad, USA 
 Gene Pulser curvette for electroporation 
 Bio-Rad Protein Assay Kit 
 Nitrocellulose membrane  
 Polyacrylamide gel reagents 
 SDS-PAGE standard markers 
 
 Clontech, USA 
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 Tet-off gene expression system kit (pTet-off plasmid and pTRE2 plasmid) 
 Tet System Approved Fetal Bovine Serum 
 Anti-GFP antibody 
  
 
 Invitrogen, USA 
 
 LipofectamineTM   
 
 Promega, USA 
 
 T4 DNA ligase 
 Restriction endonuclease 
 10x PCR buffer 
 dNTP mix 
 Taq DNA polymerase 
 DNA markers 
 
 
 Qiagen, Germany   
 QIAEX II Gel Extraction Kit  
 QIAGEN Plasmid Midi/Maxi Kit 
 
 
 Santa Cruz Biotechnology Inc, USA   
 QIAEX II Gel Extraction Kit  
 QIAGEN Plasmid Midi 
 
 
 Sigma Chemical Co. Ltd, USA   
 QIAEX II Gel Extraction Kit  
 QIAGEN Plasmid Midi 
 
 
 Stratagene, USA 
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2.2 Methods 
2.2.1 Mammalian cell culture techniques 
2.2.1.1 Maintenance of cells 
 Cells were grown in RPMI 1640 supplemented with 10% heat inactivated FBS, 
2mM L-glutamate, 50U/ml penicillin and 10µg/ml streptomycin. The cells were cultured at 
37C in a humidified 5% CO2 atmosphere.    
  
2.2.1.2 Storage of frozen cells  
 Cells to be frozen were grown up to late log phase. Adherent cells were 
trypsinized, centrifuged at 200g for 5 mins. Cells were harvested by centrifugation and 
resuspended in the freezing medium (10% DMSO, 30% FBS, 60% complete medium) at a 
density of 3 x 106 cells/ml, and portions (1 ml) are added to polypropylene freezing tubes. 
The tubes are frozen slowly at 1C/min. They were either stored in liquid nitrogen for long-
term or kept in -80C for short-term storage. 
   
2.2.1.3 Revival of frozen cells 
 Frozen stock of cell was thawed rapidly in a 37C water bath. The cells were 
transferred to a sterile tissue culture flask and appropriate volume of complete RPMI 1640 
medium was added.  The cells were then incubated in a 37C incubator with 5% CO2. 
 
2.2.1.4 Stable Transfection of cells using Electroporation 
 Chinese Hamster Ovary cells (CHO) of density (1 x 107 cells/ml of RPMI 1640 
medium) were transfected with 40µg of pTet-off plasmid DNA by electroporation (960µF, 
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750 V/cm) usng a Bio-Rad Gene Pulser. The cells were allowed to divide for 48 hrs before 
addition of geneticin (400µg/ml) to the culture for selection. Stable clones were obtained 
after 3 weeks growth in the drug-containing medium. The medium was replaced every 5 days 
with fresh medium and selection antibiotics. Clones with the best signal-to-noise ratio were 
chosen for the development of stable Tet-off cell line.   
 
2.2.1.5 Transient transfection using Liposome (Lipofectamine)  
 Introduction of foreign DNA into CHO cells was done using 
LIPOFECTAMINETM reagent (Gibco BRL)-mediated transfection method. CHO cells were 
seeded at 15% confluency and cultured until 60%~70% confluncy. For the transfection of 
cells in a 75cm2 flask, 12 mg of plasmid DNA was dissolved with 600 ml of OPTI-MEM 
reduced serum medium (Gibco BRL). Then plasmid DNA was mixed with 30 ml 
LIPOFECTAMINETM reagent which was also pre-diluted with 600 ml OPTI-MEM medium. 
The mixture was incubated at room temperature for 30 mins to allow DNA-liposome 
complex to form. CHO cells were rinsed twice with 1´PBS and one time with OPTI-MEM 
medium just before transfection. The DNA-liposome mixture was diluted with 6 ml of the 
OPTI-MEM medium and added to each of the 75 cm2 flask. The transfection was allowed for 
10 hrs in a 37°C humidified incubator with 5% CO2. The medium was changed to complete 
DMEM medium and cells were incubated for another 48 hrs. The CHO cells or culturing 
medium were harvested to detect the expression of the targeted genes. 
 
2.2.1.6 Preparation of ligands for internalization studies 
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 Different ligands were used in this study to induce internalization of wild-type 
CD38-GFP and other constructed mutants from the surface membrane in transfected CHO 
Tet-off cells. The ligands are CD38 substrate, â-NAD+, an analog of â-NAD+,  á-NAD+ 
CD38-mediated second messenger which include cADPR and cADPR analogues including 
8-Amino-cADPR. Milimolar concentration range was used for substrates like NAD+ (10mM) 
and micromolar concentration range was used for cADPR and the analogues. Ligands were 
prepared freshly with 1 x PBS on the day of experiment. The pH was then monitored within 
the range of 7-8.  
 
2.2.2 Methods for manipulation of nucleic acids  
2.2.2.1 Polymerase Chain Reaction (PCR) 
 PCR was used to exponentially amplify, mutate or subclone target DNA              
fragment. The thermostable Tag DNA polymerase (Promega) was used in the               
cycling reactions. Reactions were typically carried out in a total volume of 50ml. The reaction 
mixtures consisted of 1~20 ng DNA template, 1´PCR buffer, 2mM MgSO4, 0.2 mM dNTP 
mix, 0.2 mM each primers, 1-2 units of Tag DNA polymerase. Mineral oil could be overlaid 
or omitted to top of the reaction mixture prior to thermal cycling. Thermal cycling was 
typically carried out for 25~35 cycles of the following profile: 94°C (DNA denaturation) 
45~60 seconds, 45~60°C (primer annealing) 60 seconds, 72°C (Extension) 1~2 minutes. This 
profile was adjusted dependent on the size of the amplified DNA, template and primer used. 
The last cycles had an additional 5 minutes extension time.   
 
2.2.2.2 Cloning of full length rat CD38 cDNA into pEGFP-N1 vector 
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 As depicted in Figure 2.1, full- length rat CD38 cDNA was amplified using Pfu 
polymerase and cloned, in frame, into the pEGFP-N1 cloning vector (Clontech) at KpnI and 
EcoRI restriction sites. The sequences of the sense and anti-sense primers used in the PCR 
were 5’- CCGAATTCACCATGGCCAACTATGAATTTTC-3’ and 5’- 
ACGGTACCACATTAAGTATACATGATGG-3’. The C-terminal of CD38 was fused to the 
N-terminal of EGFP vector, thus leaving the targeting signal intact for localization and 
internalization studies. A 922 bp fragment was amplified by using the two primers mentioned 
above. DNA sequencing was carried out to ensure that no frame-shift has occur red in the 
fusion. E.coli transformed with pGFP-CD38 was screened and positive colonies were 
identified by PCR. The final construct allows the expression of CD38-GFP fusion protein.  
 
2.2.2.3 Cloning of CD38-GFP fusion gene fragment into pTRE2-hyg vector 
 The plasmid from the first cloning (pCD38-GFP) was amplified using the 
QIAGEN Maxi-kit. In order to clone this gene fragment (fusion CD38-GFP) into pTRE2-hyg 
vector, we have identified two restriction sites (Nhe I and Not I). The fusion CD38-GFP, was 
digested with Nhe I and Not I restriction enzymes and the fusion CD38-GFP was cloned into 
the Nhe I-Not I site of pTRE2-hyg vector (Figure 2.2). The plasmids with CD38-GFP insert 
were selected. DNA sequencing was carried out to ensure the gene was cloned in. The 
constructed plasmid, pTRE2-CD38-GFP was used to construct mutants using the site-
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Figure 2.1 Cloning of CD38 into pEGFP-N1 vector. CD38 was first amplified and 
digested by EcoRI and KpnI and then inserted into pEGFP-N1 vector under the 
control of HCMV promoter.  
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Figure 2.2 Cloning of CD38-GFP into pTRE2-hyg vector. Fusion gene (CD38-GFP) 
was digested with NheI and NotI enzymes before being cloned into the pTRE2-hyg 
expression vector under the control of HCMV promoter. 
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2.2.2.4 Site-directed mutagenesis by QuickChange Mutagenesis Kit 
             This in vitro multiple sites mutagenesis method used the kit from Stratagene. The 
three-step mutagenesis method is outlined in Figure 2.3. Step 1 used PCR procedure with one 
or more synthetic single-stranded 5’ phosphorylated oligonucleotide primers and cloned 
DNA in a vector as template. Double stranded DNA was generated with one strand bearing 
mutations. The nicks were sealed by components in the enzyme blend. In step 2, the reaction 
products were treated with restriction endonuclease Dpn I. The parental DNA template which 
was methylated would be digested by Dpn I endonuclease. In step 3, the mutated single 
stranded DNA was transformed into competent cells, where the mutant closed circle ss-DNA 
is converted into ds-DNA in vivo. Double stranded plasmid DNA may then be prepared from 
the transformants and analyzed by DNA sequencing to identify the clones bearing each of the 
desired mutations. 
 
2.2.2.5 Restriction endonuclease digestion of DNA 
 Digestion of DNA was normally carried out in a volume of 20 ml using      
appropriate buffers as recommended by the manufacturers. A typical digestion mixture 
consisted of: 2 mg of DNA in TE or water, 2 ml of restriction enzyme buffer (10´), 1 ml of 
restriction enzymes (5-10 U/ml) and top up with sterile water to a final volume 20 ml. The 
total amount of enzyme used did not exceed 10% of the total reaction volume so as to 
prevent “star activity” by the enzyme. Restriction mixtures were incubated at the optimal 
temperature from 1 hour to several hours. The digested DNA fragments may be separated by 
agarose gel electrophoresis. 
 























Figure 2.3 Overview of Ouickchange site-directed mutagenesis 
Step 1 
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2.2.2.6 Concentration of nucleic acids  
  Ethanol precipitation was routinely used to concentrate and purify nucleic acids.  
DNA or RNA at concentration of more than 20 mg/ml were readily precipitated with two 
volumes of absolute ethanol and sodium acetate (pH4.6) at a final concentration of 0.3 M and 
a 10 minute incubation at either room temperature or on ice. The precipitated nucleic acids 
were then pelleted by microcentrifugation at top speed for 15 minutes. The pellet was then 
washed twice with 70% ethanol at room temperature and dried. DNA or RNA at 
concentration lower than 20 mg/ml need a longer incubation time, lower precipitation 
temperature and longer centrifugation time to ensure efficiency of precipitation. 
 
2.2.2.7 DNA ligation 
 T4 DNA ligase (Promega) was used for ligation of DNA fragments into vector.               
Normally, ligation reaction was carried out at 23 °C for 4 hours or overnight at 16°C with  
vector:insert molar ratio of approximately 1:3 to increase the ligation efficiency and to 
reduce occurrences of multiple inserts. For blunt end ligations, the molar ratio of insert to 
vector can be increased to 4:1 and a buffer containing PEG 6000 to a final concentration of 
5% was used. 
 
2.2.2.8 Agarose gel electrophoresis of DNA 
            Agarose gel electrophoresis separates DNA molecules according to the size of the 
DNA fragments and the percentage of agarose in the gel used depends on the sizes of DNA 
fragments to be separated. The smaller the DNA molecule is, the higher the agarose 
concentration the gel should contain, and vice versa. For rountine gel electrophoresis, the 
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gels were made with 0.7-1.5% (W/V) electrophoresis grade agarose melted in 30 ml 1´TBE 
buffer. The gel was then cooled down to 60°C and added with 0.1 mg/ml ethidium bromide 
and poured into a horizontal gel casting tray. A comb to create the wells for loading DNA 
samples was inserted immediately into the molten agarose and left to set for 30 minutes. 
Once the gel was set, the comb was removed and the gel was submerged in an 
electrophoresis tank containing 1´TBE buffer. DNA samples were premixed with the 
appropriate amount of 10´ loading dye and loaded into the wells. Electrophoresis was 
normally carried out at 5 V/cm field strength and the migrated DNA bands were visualized 
under U.V. light.  
 
2.2.2.9 Isolation of DNA from agarose gel 
 The QIAGEN Gel Extraction kit was used for the extraction and purification of             
DNA fragments from agarose gel. The DNA band of interest was excised from the agarose 
gel under the U.V. light with a clean scalpel. The size of the excised gel was minimized as 
much as possible by trimming the excess gel. The gel slice was weighed and 3 volumes of 
buffer QXI was added to 1 volume of gel for DNA fragments from 100 bp to 4 kb. After the 
agarose gel was solubilized at 50°C, QXII solution which contained the DNA binding beads 
were added and vortexed from time to time for 10 min. After washing, DNA fragments 
bound to the beads was eluted with appropriate amount of TE buffer. The eluted DNA 
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2.2.2.10 DNA sequencing 
 Cloned DNA fragments were sequenced using the cycle-sequencing technique               
and the sequencing carried out in an automated DNA sequencer. Sequencing               
reaction is essentially a polymerase chain reaction (PCR) which employs ABI              
PRISMTM Dye Terminator cycle sequencing kit, an appropriate primer and a good quality 
double-stranded DNA template. Apart from Tag DNA polymerase and the deoxynucleotides, 
the sequencing premix also contains fluorescence tagged dideoxy-nucleotides, which emit 
different fluorescence (depending on which dideoxynuleotide), when hit by the laser. 
Reactions were carried out in a volume of 20 ml and comprised of: 500 ng of double stranded 
template DNA,  4 ml of Terminator mix, 4 ml of Half term, 3.2 pmol of Primer and add sterile 
water to a final volume 20 ml.  
          The thermal cycling was carried out using the following profiles: 
             96°C (DNA denaturation)                                                30 seconds 
             50°C (primer annealing)                                                  15 seconds 
             60°C (primer extension)                                                    4 minutes 
             The reaction was subjected to 25 cycles. 
 
 
2.2.3 Methods for bacterial culturing and transformation 
2.2.3.1  Preparation of competent cells 
 Streak LB plate with the competent cells; a single colony was picked and                
inoculated into 5 ml LB medium. After overnight growth at 37°C, 3 ml of the cultured cells 
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was inoculated into 500 ml prewarmed LB broth in a 2 liter flask and let grow till OD 600 
reached 0.5. The culture was chilled on ice for 10-15 min and transferred into a sterile, 
round-bottom centrifuge tube. Cells were collected by centrifugation at 4000g for 20 min at 
2°C. The cell pellet was then resuspended in 500 ml ice cold water and spun again. After 
washing again with cold water, cells were washed with 40 ml ice cold 10% glycerol. The cell 
pellet was finally resuspended in 1 ml ice cold 10% glycerol and aliquot 45 ml into pre-
chilled centrifuge tubes and stored in -80°C. 
 
2.2.3.2 Transformation by electroporation 
 A BioRad MicroPulser was used for high efficiency electroporation of plasmid              
into competent cells. Cell were thawed and stored on ice, then 1 ml of ligation              
product was added and mixed with the cells. The mixture was transferred to a cold 0.2 cm 
electroporation cuvette. This was then pulsed once at a voltage of 1.8 kV. 1 ml SOC medium 
or LB medium was immediately added to the cuvette to resuspend the cells. Cells were then 
transferred to a 10 ml culture tube and incubated at 37°C for 1 hr with shaking at 200rpm. 
Different volumes of culture were plated onto LB plate containing appropriate antibiotics to 
ensure selection of colonies. 
 
2.2.3.3 Transformation by heat shock 
  45 ml of competent cells in polypropylene tubes were thawed on ice. After                
adding 2 ml of b-ME mix into each tube of the cells, the mixture was swirled gently and 
incubated on ice for 10 min with swirling gently every 2 min. Transfer 1.5 ml of the DNA to 
be transformed into the cell mixture, swirl and incubate on ice for another 30 min. The tube 
Chapter 2 Materials and Methods   46 
was then heat-pulsed in a 42°C water bath for 30 sec, then incubated on ice for 2 min. 0.5 ml 
of preheated (42°C) LB medium was added into each tube and incubated at 37°C for 1 hr 
with shaking of 225-250 rpm. Appropriate volume of the transformation mixture was plated 
onto agar plates containing the appropriate antibiotics fo r the plasmid vector. The 
transformation plates were incubated at 37°C for >16 hr.  
 
2.2.4 Preparation of plasmid DNA from Bacterial cells 
 Isolation of plasmid DNA was performed on either a small or ‘miniprep’ scale to 
obtain sufficient material for analysis, or on a large, ‘maxiprep’ scale to provide a stock of 
plasmid for long-term use. 
 
2.2.4.1 Miniprep  
 This proceed was carried out using Wizard ®Plus SV Minipreps DNA 
Purification System. Individual bacterial clones were picked and dispersed into separate 
sterile tubes that contain 3 ml of LB and the appropriate antibiotics. The tubes were shaken 
overnight at 37C overnight. The culture was pelleted by centrifugation for 2 minutes at 
10,000 × g in a microcentrifuge. The supernatant was poured off and blot the tube upside-
down on a paper towel to remove excess media. The cell pellet was resuspended in 250µl of 
Cell Resuspension Solution (50mM Tris-HCl (pH 7.5), 10mM EDTA, 100µg/ml RNase A). 
250µl of Cell Lysis Solution (0.2M of NaOH, 1%SDS)  was added and mixed by inverting 
the tube 4 times. The cell suspension should clear immediately. 10µl of Alkaline Protease 
Solution was added and mixed by inverting the tube 4 times and incubated for 5 minutes at 
room temperature. Alkaline protease inactivates endonucleases and othe r proteins released 
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during the lysis of the bacterial cells that can adversely affect the quality of the isolated 
DNA. 350µl of Neutralization Solution (4.09M guanidine hydrochloride, 0.759M potassium 
acetate, 2.12M glacial acetic acid) was added immediately and mixed well.  The bacterial 
lysate was centrifuged at maximum speed (around 14,000 × g) in a microcentrifuge for 10 
minutes at room temperature.  
 After centrifugation, the cleared lysate was transferred to the prepared Spin 
Column. The supernatant was spun at maximum speed for 1 min and the flowthrough was 
discarded. The Spin Column was washed with 750µl Column Wash solution twice by 
centrifugation and the flowthrough was discarded. The Spin Column was transferred to a new 
sterile microcentrifuge tube and the plasmid DNA was eluted by adding nuclease-free water 
to the Spin Column and spun for 2 min. After eluting, the Spin Column can be discarded and 
the purified plasmid DNA can be stored at -20C for future use. 
 
2.2.4.2 Midi/Maxiprep 
 Large-scale plasmid DNA preparations were carried out using QIAGEN Plasmid 
Midi/Maxi Kit. The bacterial cells were harvested by centrifugation at 6,000 x g for 15 min at 
4C. The pellet was resuspended in Buffer P1 and mixed with the same volume of Buffer P2. 
After incubation at room temperature for 5 min, Buffer P3 was added and mixed 
immediately. The sample was incubated on ice for 20 min and then centrifuged at 12,000 x g 
at 4C for 30 min and 15 min once each. The supernatant was then applied to the pre-
equilibrated QIAGEN-tip 100/500 column and was washed with Buffer QC twice. After that, 
the DNA was eluted with Buffer QF and precipitated with 0.7 vol of isopropanol. The 
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precipitated DNA was centrifuged at 16,000 x g for 15 min. After washing with 70% ethanol 
and air-drying, the DNA was re-dissolved in a suitable volume of TE buffer. 
 
2.2.5 Expression, purification and analysis of CD38 
2.2.5.1  Membrane protein harvesting   
 The transfected CHO Tet-off cells with the wild-type CD38 and its mutants were 
harvested for its membrane proteins following 48hr post-transfection. Briefly, the cells were 
scraped from the culture flasks and protease inhibitor cocktail containing leupeptin and 
aprotinin (10µg/ml), 50µg/ml soybean trypsin inhibitor and 100µM phenylmethysulfonyl 
fluoride were added immediately to the cells resuspended in 1 x PBS. The cell lysate was 
then homogenized with a polytron homogenizer for a brief period of 1 min. The cells were 
then pelleted at 1000 x g for 10min and the process was repeated again. The supernatants 
collected were pooled and spun at a higher speed of 6000 x g for 30min. The pellet that was 
recovered was resuspended in cold 1 x PBS stored at -20C for future use. Protein 
concentration was determined by Bradford protein assay (Bio-Rad) with bovine serum 
albumin as a standard, according to manufacturer’s instructions. 
 
2.2.5.2 SDS-Polacylamide gel electrophoresis (SDS-PAGE) 
 The preparation of SDS-PAGE was carried out following the well-established 
Laemmli system (Laemmli, 1970). Briefly, to prepare 10% SDS-PAGE gel, 10  ml and 3 ml 
of separating and stacking gel solutions were prepared according to the following menu, 
respectively. 
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Stock Solution                   Separating Gel (ml)               Stacking Gel (ml)      
dH2O                                             4                                             2.3 
30% Acrylamide (29:1)                3.3                                           0.3 
1.5 M Tris-HCl (pH8.8)                2.5                
1 M Tris-HCl (pH6.8)                                                                  0.38 
10% SDS                                       0.1                                          0.03 
10% APS                                       0.1                                          0.03 
TEMED                                         0.004                                      0.003 
 
 APS and TEMED were added to the solution immediately before casting the gel. 
The separating gel solution was poured into the vertical gel caster (Bio-Rad) first and left to 
set at room temperature before pouring in the stacking gel and placing the comb. Once the 
stacking gel was set in the caster, it was fixed into the vertical electrophoresis unit. Protein 
samples were mixed and boiled for 5 min with protein loading buffer and loaded into the 
wells of the PAGE gel. Electrophoresis was carried out at 100 V until the protein sample 
entered the separating gel then increased to 200 V. After the electrophoresis, the gel can be 
stained with coomassie blue staining solution or proceed for Western blotting. 
 
2.2.5.3 Staining of SDS-PAGE gel with Coomassie Blue  
 The electrophoresed SDS-PAGE gel was detached from the glass plates and was 
submerged in Coomassie Blue dye (0.025% Coomassie G250, 0.025% Coomassie R250, 
25% isopropyl alcohol, 10% acetic acid). Staining was carried out for at least 2 hours with 
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gentle shaking. It was then transferred into destaining solution (10% acetic acid and 40% 
methanol in water) and was allowed to destain for 2 hours to overnight with one or two 
changes of the solution. The destained gels were visually examined. 
 
2.2.5.4 Western Blot 
 Protein samples were separated on SDS-PAGE as described above in 2.2.5.3 and 
transferred to nitrocellulose membrane using a wet transelectroblotting system (Bio-Rad  
Inc., England) at a low voltage of 80 V for 2hr. The transfer buffer consist of 150mM Tris-
HCl, 39mM glycine and 20% methanol with a final pH of 8.3. The membrane was then 
blocked in TBS-T (20mM Tris, 137 mM NaCl, pH7.5, 0.1% Tween 20) containing 5% non-
fat milk for 1 hour. After incubating in appropriate primary antibody for 1-2 hours at room 
temperature, the membrane was washed three times with TBS-T buffer, 15 min each time to 
remove the excess antibodies. Then, the membrane was incubated in horseradish peroxidase-
conjugated secondary antibody for 1 hour at room temperature. The unbounded secondary 
antibodies were washed away with TBS-T buffer three times, 10 min each wash. The 
immunoreactive bands were detected by enhanced chemiluminescence (ECL) reagent 
exposed to a Fuji X-ray film and processed by a KODAK film processor. 
2.2.5.5 Stripping and reprobing of membranes 
 After each immunodetection, the bound primary and secondary antibodies can be 
removed from the membrane and the membrane can be reprobed using different antibodies 
following the method below: Submerge the membrane in stripping buffer (100 mM 2-
mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH6.7) and incubated at 50°C for 30 min 
with occasional agitation. The membrane was then washed with large volume of TBS-T 
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buffer for two times at room temperature, 10 min each time. Block the membrane by 
immersing in 5% non-fat milk in TBS-T for 1 hour at room temperature. The membrane is 
ready to be reprobed by a different antibody with same protocol described above in 2.2.5.4. 
 
2.2.5.6 Enzyme Assays for CD38 
 The ADP-ribosyl cyclase and cADPR hydrolase activities of wild-type or mutant 
CD38 were measured with the alternative substrates of NGD and cIDPR, respectively. 
Membrane fractions from wild-type and mutant CD38 were incubated for 15 min at 37C in 
20mM Tris-HCl (pH 7.4) with 100µM NGD or cIDPR. CD38 cyclizes a non-fluorescent 
substrate NGD into a fluorescent product, cyclic GDP-ribose. Since cyclic GDP-ribose is 
highly resistant to hydrolysis, we have used cyclic IDP-ribose, which can be readily 
hydrolyzed by CD38 to indicate the hydrolase activity of wild-type CD38 and its mutants. 
The fluorescence was measured using a high sensitivity Perkin Elmer LS 50B 
spectrofluoremeter (excitation wavelength = 300nm; emission wavelength = 410nm). 
 
2.2.5.7 Affinity purification of biotinylated CD38 
 In a typical experiment, CHO Tet-off cells were transfected with the wild-type 
CD38-GFP and W163G mutant plasmid. After 48h transfection, the cells in culture medium 
were washed in RPMI without serum and incubated in PBS containing 5 mM glucose, 0.1 
mM CaCl2, 1 mM MgCl2, and 0.8 mM NHS-SS-biotin for 20 min at 4°C. Cells were then 
washed in RPMI containing 0.2% bovine serum albumin (fatty acid free) and incubated in 
complete medium in the presence or absence (control) of 10 mM NAD+ for 2 h at 37°C. Cells 
were then incubated in RPMI with 50 mM GSH at 37°C for 5 min to remove the surface 
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biotin from control and NAD+ -treated cells. To remove untreated GSH, cells were washed in 
PBS containing iodoacetamide (5 mg/ml). Finally, cells were solubilized in lysis buffer [PBS 
containing 1% Triton X-100, 5 mM EDTA and protease inhibitor cocktail containing 
leupeptin and aprotinin (10 mg/ml), 50 mg/ml soybean trypsin inhibitor, and 100 mM PMSF] 
at 4°C. The supernatants were obtained from cell lysates by centrifugation at 10,000g for 10 
min at 4°C, and the supernatants were incubated with immobilized streptavidin, at 300 µl 
resin/ml, for 2 h at 4°C with shaking. The flowthrough was recovered by centrifugation at 
200g for 5 min. The resin was washed with lysis buffer and the adsorbed (i.e. biotinylated) 
proteins were eluted with 0.1 M glycine buffer, pH 2.0. It was immediately neutralized with 
1 M Tris–HCl, pH 8.3. The eluate and flowthrough from control and NADP+- treated cells 
were dialyzed in 10 mM Tris–HCl, pH 7.2, containing 0.1% Triton X-100 for 16 h at 4°C, 
and then concentrated using Centricon 30 (Amicon Inc., Beverly, MA).  
 
2.2.5.8 Confocal microscopy of CD38 expression and localization 
 Confocal microscopy was performed using a Carl Zeiss LSM 510 confocal 
microscope, equipped with a 40 x Fluar objective (NA = 1.3), 63 x Plan-Apochromatic 
objective (NA = 1.4) and a 100x Fluar objective (NA = 1.3), oil immersion. CHO Tet-off 
cells were grown on glass coverslip in culture medium and were transiently transfected with 
the following plasmids, wild-type pTRE2hyg-CD38-GFP, pEGFP-N1 (positive control), 
pTRE2hyg plasmid (negative control), mutated pTRE2hyg-CD38-GFP at Cys-122 site,  
mutated pTRE2hyg-CD38-GFP at Glu-229 site, mutated pTRE2hyg-CD38-GFP at 
Leu-149 site and mutated pTRE2hyg-CD38-GFP at Trp-162 site. The analysis was to 
examine the distribution of wild-type CD38-GFP protein and its mutants in CHO Tet-off 
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cells with the use tetracycline drug. Tetracycline was added initially to switch off the 
expression of the protein and was removed by washing with 1 x PBS and the expression  of 
the different proteins were allowed to be studied. After 48h post transfection, the cells were 
fixed with 3.7% paraformaldehyde for 10 min. The cells were then mounted for confocal 
viewing.  
 
2.2.5.9 Live-imaging of CD38 internalization 
 Different ligands including á-NAD+,  â-NAD+, cADPR and 8-NH2-cADPR were 
tested on the Tet-off CHO cells transfected with wild-type and mutation plasmids. Milimolar 
concentration range was fixed for substrates like NAD+. For secondary messenger like 
cADPR and the analogues, we have used micromolar concentrations, which is in line with 
the physiological range. The above mentioned ligands were dissolved in 1 x PBS under 
sterile condition and the pH was closely monitored within range of 7-8.    
 The transfected CHO Tet-off cells with the wild-type CD38 and its mutant 
plasmids were subjected to 2 hr incubation with the above-mentioned ligands following the 
48hr post-transfection and the images of the cells were taken at a few time intervals (0, 30, 
60 and 120 min). 
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3.1 Cloning of full length rat CD38 cDNA into pEGFP-N1 vector 
 As mentioned in the previous section (2.2.2.2), full- length rat CD38 cDNA 
was amplified using Pfu polymerase and cloned, in frame, into the pEGFP-N1 cloning 
vector (Clontech) at Kpn1 and EcoR1 restriction sites. The sequences of the sense and 
anti-sense primers were 5’- CCGAATTCACCATGGCCAACTATGAATTTTC-3’ and 5’- 
ACGGTACCACATTAAGTATACATGATGG-3’. The C-terminal of CD38 was fused to 
the N-terminal of EGFP vector, thus leaving the targeting signal intact for localization and 
internalization studies. A PCR product of 922 bp fragment was amplified by using the two 
primers mentioned above and a product of ~900bp was obtained (Figure 3.1, lane A). 
Upon digestion of pEGFP-vector with EcoR1 and Kpn1, a fragment of ~4680 bp was 
obtained (Figure 3.1, lane B). Sequences at the fusion point were confirmed by DNA 
sequencing to ensure that no frame-shift has occurred. E.coli transformed with pGFP-
CD38 was screened and positive colonies were identified by PCR and the complete 
sequence of rat CD38 insert sub-cloned into pEGFP-vector was verified by DNA 
sequencing (data not shown).  
 
3.2 Cloning of CD38-GFP fusion gene fragment into pTRE2-hyg vector 
 The plasmid from the first cloning (pCD38-GFP) was amplified using the 
QIAGEN Maxi-kit (described in Section 2.2.4.2). In order to clone this gene fragment into 
pTRE2-hyg vector, we have identified two restriction sites (Nhe 1 and Not 1). The fusion 
CD38-GFP was digested with Nhe 1 and Not 1 restriction enzymes and a fragment of 
~1674 bp was obtained and sub-cloned into the Nhe 1-Not 1 site of digested pTRE2-hyg 
vector. The plasmids with CD38-GFP insert were selected. DNA sequencing was carried 
out to ensure this fusion gene was cloned in. The constructed plasmid, pTRE2-hyg-CD38-
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GFP was used to study site-directed mutagenesis of CD38 using the mutagenesis kit 
mentioned in the next section. Figure 3.2 shows the detailed agarose gel analysis of the 
PCR products and the constructed plasmid. 
 
3.3 Effects of amino acid  substitution of CD38 on cADPR metabolism 
 Previously, it has been reported that some amino acid residues affect the 
enzymatic activities, ADP-ribosyl cyclase and cADPR hydrolysis, of human CD38 (Shan 
et al., 1995; Lee 2000; Lee 2001). By this, we hope to obtain valuable information from it 
to investigate the effect of enzymatic activities on ligand-dependent internalization in rat 
CD38. To investigate on the importance of enzymatic roles during internalization, we 
have compared the amino acid sequences of human, rat, mouse CD38s and Aplysia ADP-
ribosyl cyclase (Figure 3.3). The rat, human and mouse CD38s are known to possess both 
ADP-ribosyl cyclase and cADPR hydrolase activity. Since it has been previously reported 
that amino acid residues Cys-119 and Cys-201 in human CD38 play crucial roles in the 
synthesis and hydrolysis of cADPR (Tohgo et al., 1994), we would like investigate if the 
corresponding mutation of Cys-122 residue, corresponding to Cys-119 in human CD38 
will affect internalization in rat CD38. Furthermore, the di- leucine motif has been reported 
in some studies, which might play an important role in the process of membrane protein 
internalization. Therefore from the sequence comparison, we have selected one of the 
leucine residues, Leu-149, present in the extracellular domain of rat CD38 for site-directed 
mutagenesis. Both amino acid residues in human CD38, Trp-140 and Glu-226, have also 
been reported previously for their important role in enzymatic activities. In this study, we 
have also selected Trp-162 and Glu-229 in rat CD38 for our mutation studies to see its 
effect on ligand-induced internalization processes.  













                                          
 
Figure 3.1: DNA gel. The rat CD38 cDNA was amplified by using the appropriate 
primers which gave a ~900 bp inserts. Lane A: PCR product from rat CD38 cDNA.                                         
Lane B: EcoR1 and KPN1 digested pEGFP-N1 vector. Lane M1: 100bp markers. Lane 
M2: Lambda Hind III markers. 
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Figure 3.2 Agarose gel of PCR products and constructed plasmids. PCR product of rat 
CD38 was digested with EcoR1 and KpN1 and cloned into the EcoR1-Kpn1 site of 
pEGFP-N1 vector (Lane A). The fusion pCD38-GFP as shown in Lane A was excised at 
Nhe I and Not I sites (lane B, 1647 bp) and sub-cloned into the pTRE2-hyg vector. The 
constructed pTRE2-hyg-CD38-GFP (Lane C) was digested at both Nhe 1 and Not 1 sites. 
The final cloned plasmid (Lane D) was checked again by double-digestion (Nhe 1 and Not 
1), which showed the corresponding bands. Lane M1 and M2: 100bp DNA marker and 
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Figure 3.3 Sequence homology of rat, mouse and human CD38. The predicted amino 
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3.4 Site-directed mutations of CD38 
 One of the site-directed mutations that we have performed was to replace Cys-
122 residue with Lysine (as found in Aplysia cyclase) in rat CD38 cDNA. The resulting 
cDNA construct was expressed transiently in CHO Tet-off cells. We have constructed 
several other CD38 mutants in which the mutations were identified to be critical for 
catalysis as well as internalization. We made 3 other mutants in which the Leu-149, Glu-
229, Trp-162 were replaced with valine, glycine and glycine respectively, and introduced 
the mutants into CHO Tet-off cells.  
 The site-directed mutants were constructed using the QuickChange Site-
directed Mutagenesis Kit obtained from Stratagene (as described in Section 2.2.2.4). This 
method utilizes Pfu Turbo DNA polymerase and mutant oligonucleotide primers to 
generate the desired mutations in the super-coiled plasmid vector containing the inserts of 
interest. The following oligonucleotide primers were generated for the mutations: 
 
 E229G primer:  
 5’-PO4- GCACCTTTGGAAGTGTGGGAGTCTTTAATTTGGACCC-3’ 
  
 L149V primer:  
 5’-PO4- TTCACCCTGGAGGACACAGTGCTGGGCTATATTGCAG-3’ 
  
 C122K primer:  
 5’-PO4- GGTTACTCAAACCATACCAAAGAACAAGACTCTCTTTTG-3’ 
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 W162G primer: 
 5’-PO4- GCAGATGATCTCAGGGGATGTGGAGACCCCAGTACTTCC-3’ 
 
Following that, the product is treated with Dpn I endonuclease which specifically digest 
the hemi-methylated parental DNA strand leaving behind the mutation containing 
synthesized DNA. Plasmid DNA isolated from most E.coli strain is dam methylated which 
can be digested with Dpn I enzyme. The desired mutant is transformed into XL1-Blue 
super-competent cells. The mutant clones were selected and confirmed by DNA 
sequencing.  
   
3.5 Transfection of CHO Tet-off cells 
 Once the wild-type CD38 and the constructed mutants have been confirmed by 
DNA sequencing and restriction enzyme analysis, CHO Tet-off cells (see section 2.2.1.4) 
were transfected with the plasmids by Lipofectamine (Invitrogen).  Transfected cells were 
cultured for 48h and harvested for the preparation of total cell lysate. The membrane 
proteins of the transfected cells were resolved on SDS-PAGE under reducing conditions 
and subsequently immunoblotted with polyclonal rabbit anti-rat CD38 primary antibody. 
The results are shown in Figure 3.4. The level of expression of all mutant proteins was 
roughly comparable to that observed with the wild-type CD38-GFP protein. These data 
suggest that site-directed mutations do not interfere with the level of expression of the 
constructed mutants. The expression of GFP was also determined in the 
CHO Tet-off cells by transfecting with  pEGFP-NI control plasmid alone and resolving on 
SDS-PAGE under reducing conditions. The GFP expression alone was confirmed by 
immunoblotting with anti-GFP antibody, which shows a band of 29kDa (Figure 3.5). 















Figure 3.4 Transfection of wild-type CD38 and mutants. Wild-type CD38 and mutants 
(C122K, E229G, L149V and W162G) were transiently transfected in the CHO Tet-off 
cells. 48h after post-transfection and removal of tetracycline, the membrane protein were 
harvested and analyzed by Western blot. 20µg of each sample was subjected to 10% SDS-
PAGE under reducing conditions. The position of CD38-GFP fusion protein bands was 
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The localization of GFP expression, wild-type fusion CD38-GFP protein and non-
transfected CHO-Tet cells (data not shown) were further confirmed with confocal 
microscopy as shown in Figure 3.6. 
 
3.5 Tetracycline regulated expression of Wild-type CD38 
 To study CD38 internalization with the Tet-Off system, it is particularly 
important to know the kinetics of induction and inactivation of gene expression. A more 
direct test for the regulated expression studies of CD38 would be transfecting CHO cells 
with a Tet-off expression construct containing wild-type CD38. The expression system 
can be regulated by treating the transfected CHO Tet-off cells with tetracycline. We first 
tested the addition of tetracycline to the wild-type CHO cells to ensure that it has no effect 
on the morphology changes of the cells.  We have optimized the amount of tetracycline to 
add in order to switch off the protein expression over a time period and confirmed that 
tetracycline did not lead to any cell toxicity and rTA function remained stable in the 
course of transfection. A concentration of 2mg/ml tetracycline was chosen (Figure 3.7). 
This dosage was considered non-toxic since toxic effects. Changes in cell morphology 
were only observed at concentrations higher that 6mg/ml (data not shown). 
 We attempted to express wild-type CD38 in the CHO Tet-off cells to check the 










Figure 3.5 Immunoblot analysis of GFP protein alone and wild-type CD38-GFP fusion 
protein. Detection of CD38-GFP and GFP alone from crude membranes of CHO Tet-off 
cells transfected with pCD38-GFP and pEGFP-NI alone with Western Blot using 
monoclonal antibody to GFP as the primary antibodies. The crude membrane fractions 
were subjected to 10% (w/v) SDS-PAGE under reducing conditions (0.04 M b-
mercaptoethanol in the sample buffer), followed by blotting onto the nitrocellulose 
membrane and probing with mouse monoclonal anti-GFP primary antibody and secondary 
anti-mouse antibodies conjugated to horseradish peroxidase were used before subjected to 
ECL system. Lane 1, crude membranes from the wild-type pCD38-GFP transfected CHO-
Tet cells. Lane 2, crude membranes from pEGFP-NI transfected CHO-Tet-off cells. Lane 
3, crude membranes from the non-transfected CHO-Tet-off cells. The antibodies 
recognized a single band of approximately 74-kDa characteristic of the fusion protein of 
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Figure 3.6 Transfection of pEGFP-NI vector and wild-type pTRE2-Hyg-CD38-GFP into 
CHO Tet-off cells. The expression of wild-type CD38-GFP at the plasma membrane was 
detected by confocal microscopy. Phase contrast image (A) of CHO Tet-off cells 
transfected with pEGFP vector. Phase contrast image (C) of CHO Tet-off cells transfected 
with wild-type pTRE2-Hyg-CD38-GFP. GFP fluorescence as shown in B & D. Size of bar 
= 20 µm.    
 
 













Figure 3.7 Determination of optimal concentration of tetracycline. CHO Tet-off cells 
were stably transfected with a plasmid expressing CD38-GFP under control of the TRE 
and grown in the presence of the indicated amounts of Tc. A Western blot containing 100 
mg of total protein from each condition was probed with mouse anti-GFP specific 
monoclonal antibodies and secondary anti-mouse antibodies conjugated to horseradish 
peroxidase were used before subjected to ECL system. A concentration of 2mg/ml was 
chosen for subsequent experiments. The equal loading of membrane protein was 
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cells transfected with the wild-type CD38, with the removal of tetracycline, it has reached 
optimal expression of the fusion protein, CD38-GFP (74–kDa) at 48h as shown by 
Western-blot. The equal loading of lysate proteins was judged by the level of the house-
keeping gene, â-actin (42-kDa). This was further confirmed by enzymatic assay  as shown 
in Figure 3.9 (A) using wild-type CD38 membrane extracts obtained at 48h. At 0h, the 
presence of tetracycline inhibited the protein expression. The extent of increase in CD38 
cyclase activity after 48h which is induced by removal of tetracycline is significantly 
higher than cells with tetracycline. We also observed the hydrolase activity of CD38 was 
also optimal at 48h after the removal of tetracycline. Furthermore, we see that CD38-GFP 
expression on the surface membrane reached its maximum level via confocal microscopy 
within 48h after removal of tetracycline from the growth medium as seen in Figure 3.9 
(B).  These data support the notion that wild-type CD38 level of expression can be 
regulated via the drug, tetracycline.    
 
3.7 Relative percentage of enzyme activities of CD38 mutants 
 The relative enzymatic activities of each mutant expressed as a percentage of 
both ADP-ribosyl cyclase and cADPR hydrolase activities of the wild-type rat CD38 are 
shown in Figure 3.10. Wild-type CD38 exhibited both ADP-ribosyl cyclase and cADPR 
hydrolase activities (Figure 3.10, wild-type, lane 1). This enzymatic activity is critical for 
the cyclization of NAD+ which produces cADPR essentially for Ca2+ release. ADP-ribosyl 
cyclase activity was detected not only in the mutant Cys-122 but also in the mutant having 
one of the leucine residues (L149V) replaced. However, we could only detect low levels 
of ADP-ribosyl cyclase in the W162G mutant. In contrast with ADP-ribosyl 
cyclase, the cADPR hydrolase activity was not detected in C122K and L129V mutants  













Figure 3.8 Regulation of wild-type CD38-GFP protein expression using tetracycline. Top 
panel: Wild-type CD38-GFP was transfected into tetracycline regulated Chinese Hamster 
Ovary (CHO) cells. CHO cells containing the Tet-off system, in the presence of (+) 
tetracycline, CD38-GFP expression is off (not expressed), whereas in the absence of (-) 
tetracycline, CD38-GFP is expressed. After 48 hours of incubation with or without 2µg/ml 
of tetracycline, membrane proteins were harvested at 12, 24, 36 and 48h and analyzed by 
Western blot for expression level of CD38-GFP (74-kDa) as described in Material and 
Methods. The equal loading of membrane protein was determined by the level of â-actin 
(42-kDa) expression (shown in the bottom panel). Maximum level of protein expression 
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Figure 3.9 (A) Enzyme assays. Top panel: The ADP-ribosyl cyclase activity of wild-type 
CD38-GFP was measured fluorometrically as the production of cGDPR from the substrate 
NGD+. At time 0h, the (+) presence of tetracycline inhibit the expression of CD38 resulted 
in no detectable enzymatic activity. At 48h after which tetracycline was removed, the 
presence of ADP-ribosyl cyclase was shown. Bottom panel: The cADPR hydrolase of the 
wild-type CD38-GFP was measured with the use of cyclic IDP-ribose, which can be 
readily hydrolyzed by CD38 to indicate the hydrolase activity. At 0h, the hydrolase 
activity was inhibited by the presence of tetracycline. At 48h after tetracycline was 
removed, the presence of hydrolase activity was detected.  
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Figure 3.9 (B) Effect of tetracycline on CD38-GFP expression. The effect of tetracycline 
was again confirmed by confocal scanning laser microscopy. At 0h, the presence of 
tetracycline has inhibited the expression of the green fluorescent protein (A) phase 
contrast image of CHO Tet-off cells transfected with pTRE2-hyg-CD38-GFP (B) 
fluorescent image. As shown in (C) phase contrast image of CHO Tet-off cells transfected 
with pTRE2-hyg-CD38-GFP, the surface membrane fluorescence of CD38-GFP (D) was 

































Figure 3.10 Relative enzymatic activities of each mutant as a percentage of the 
activity of the wild-type rat CD38. Relative ADP-ribosyl cyclase and cADPR hydrolase 
activities of the mutants of CD38-GFP. The data show three independent experiments 
with different sets of transfected cells. Bar chart shows the average results from the three 
experiments. Error bar represent the standard errors from the mean. The cyclase and 
hydrolase activities are expressed as nmoles cGDPR produced/min/mg of protein and 
nmoles cIDPR hydrolyzed/min/mg protein, respectively. (*) represent tha t hydrolase and 
cyclase activities below detection (<1pmol/min/mg protein). The homogenate of CHO 
Tet-off cells transfected with pTRE2-hyg did not show any ADP-ribosyl cyclase or 
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(Figure 3.10, lane 2 and 3 respectively), but cADPR hydrolase activity was detected in 
Trp-162 mutant as shown in (Figure 3.10, lane 5). Neither ADP-ribosyl cyclase activity 
nor cADPR hydrolase activity was detected in the other mutant, E229G (Figure 3.10, lane 
4).  
 
3.8 Expression of CD38 and mutants in CHO Tet-off cells 
 The membrane surface expression of wild-type CD38, C122K, L149V and 
W162G mutants were confirmed by transfecting the individual plasmids and expressing 
them in CHO Tet-off cells. We observed that E229G mutant was the only one that was 
found at the cytoplasmic location as shown in Figure 3.11. The wild-type CD38 and the 
rest of the mutants (C122K, L149V and W162G) were found to be expressed n the plasma 
membrane 48h after transfection.  
  
3.9 Live-imaging of NAD+ -induced internalization of CD38  
 Previous studies have shown that GSH- and NAD+ could induce internalization 
of plasma membrane CD38 in Namalwa B cells, HeLa, and 3T3 cells (Zocchi et al., 
1996). Here we have studied the internalization of wild-type CD38 and the constructed 
mutants with the using three different internalization inducing agents, 10mM of â-NAD+, 
10ìM of cADPR and 10ìM of 8-NH2-cADPR. cADPR has been reported to be powerful 
Ca2+ mobilizers in different cell types. However the of â-NAD+ analog, á-NAD+ , failed to 
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Figure 3.11 Localization of the wild-typeCD38-GFP and mutants in CHO Tet-off cells. 
Wild-type CD38 and constructed mutants were transfected into CHO Tet-off cells. The 
expression of CD38-GFP was detected by confocal scanning laser microscopy. (A) WT 
CD38-GFP (B) C122K mutant (C) L149V mutant (D) W162G mutant (E) E229G mutant 
The expression was visualized with a confocal microscope after 48h post-transfection and 
removal of tetracycline. Scale bar = 20 µm. 
Chapter 3 Results  74 
 The tetracycline was removed after 12h incubation and expression of wild-type 
CD38-GFP and the mutants were allowed for the next 48h. After which, the ligand â-
NAD+ was added to the CHO Tet-off cells transfected wild-type CD38, C122K, L149V 
and W162G mutants. The images were taken at a few time intervals (0, 30, 60, 120 min) 
to observe the internalization of wild-type CD38-GFP and the mutants. We have excluded 
the mutant, E229G for the live- imaging internalization study because the mutant was not 
able to be expressed on the plasma membrane of CHO Tet-off cells. As shown in (Figure 
3.12 A, B, C and D), the effect of â-NAD+ on the internalization of wild-type CD38 and 
C122K, L149V and W162G, respectively, in CHO Tet-off cells were detected by the 
confocal microscopy for a period of over 2h. The green fluorescence on the plasma 
membrane of wild-type CD38, C122K and L149V mutants decreased over a period of 
time and cluster of fluorescence were observed in the cytoplasm location (as indicated by 
the arrows). However, the fluorescence on the plasma membrane of W162G mutant 
remained after 2h incubation with â-NAD+. No detectable fluorescence of CD38 was 
found in the cytoplasm (Figure 3.12 D).  
 
3.10 Live-imaging of internalization of CD38-GFP with cADPR and  8-NH2-
cADPR ligand 
 Similar live- imaging experiments using cADPR and 8-NH2-cADPR on 
internalization of wild-type CD38, C122K, L149V and W162G revealed that these had the 
same effect as â-NAD+ (Figure 3.13 A and Figure 3.13 B). These results further confirmed 
that the presence of functional ADP-ribosyl cyclase activity is needed for the 
internalization of wild-type CD38 and with intact ADP-ribosyl cyclase activity in CHO 
Tet-off cells. Thus, with a significant decreased in the cyclase activity in the W162G 
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mutant, it was unable to undergo internalization with the above-mentioned ligands (Figure 
3.12 D, Figure 3.13A & B, Lane 3).  








Figure 3.12 (A) CHO Tet-off cells were transfected with wild-type CD38-GFP. After 48h 
post-transfection and removal of tetracycline, the ligand â-NAD+ was added. The real-
time internalization of the transfected cells were captured at a few time intervals (0, 30, 60 
and 120 min). The arrows indicate the clustered fluorescence of CD38 being internalized, 
and localized in the cytoplasmic location of the cell and ultimately near the peri-nuclear 
region, while less green fluorescence was displayed on the surface membrane over the 
time period. Cells under ligand treatment was subjected to optical sections of 1µm 
thickness using a Plan-Apochromat 63X/1.4 Oil DIC Fluar Zeiss objective with a zoom of 











Figure 3.12 (B) CHO Tet-off cells were transfected with mutant CD38-GFP, C122K. 
After 48h post-transfection and removal of tetracycline, the ligand â-NAD+ was added. 
The real-time internalization of the transfected cells were captured at a few time intervals 
(0, 30, 60 and 120 min). The arrows indicate the clustered fluorescence of CD38 being 
internalized, and localized in the cytoplasmic location of the cell and ultimately near the 
peri-nuclear region, while less green fluorescence was displayed on the surface membrane 
over the time period. Cells under ligand treatment was subjected to optical sections of 
1µm thickness using a Plan-Apochromat 63X/1.4 Oil DIC Fluar Zeiss objective with a 











Figure 3.12 (C) CHO Tet-off cells were transfected with mutant CD38-GFP, L149V. 
After 48h post-transfection and removal of tetracycline, the ligand â-NAD+ was added. 
The real-time internalization of the transfected cells were captured at a few time intervals 
(0, 30, 60 and 120 min). The arrows indicate the clustered fluorescence of CD38 being 
internalized, and localized in the cytoplasmic location of the cell and ultimately near the 
peri-nuclear region, while less green fluorescence was displayed on the surface membrane 
over the time period. Cells under ligand treatment was subjected to optical sections of 
1µm thickness using a Plan-Apochromat 63X/1.4 Oil DIC Fluar Zeiss objective with a 












Figure 3.12 (D) CHO Tet-off cells were transfected with mutant CD38-GFP, W162G. 
After 48h post-transfection and removal of tetracycline, the ligand â-NAD+ was added. 
The real-time internalization of the trans fected cells were captured at a few time intervals 
(0, 30, 60 and 120 min). No internalization of CD38-GFP was observed in this case. The 
green fluorescence was displayed on the surface membrane. Cells under ligand treatment 
was subjected to optical sections of 1µm thickness using a Plan-Apochromat 63X/1.4 Oil 
DIC Fluar Zeiss objective with a zoom of 2 times and visualized at a mid-height of the 
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Figure 3.13 (A) Real- time live imaging of ligand- induced internalization of wild-type 
CD38-GFP and mutants using cADPR. CHO Tet-off cells were transfected with wild-type 
CD38-GFP (1) C122K (2) and W162G (3). After 48h post-transfection and with the 
removal of tetracycline, 10ìM cADPR was added. The real-time internalization of the 
transfected cells were captured at 2 time intervals (0 and 120 min). The arrows indicate 
the clustered fluorescence of CD38 being internalized, and localized in the cytoplasmic 
location of the cell and ultimately near the peri-nuclear region, while less green 
fluorescence was displayed on the surface membrane over the time period. CHO Tet-off 
cells transfected with W162G mutant (3), cADPR has no effect on internalization of 
CD38. Surface membrane fluorescence remained. Scale bar = 20 µm. 
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Figure 3.13 (B) Real- time live imaging of ligand-induced internalization of CD38-GFP 
mutants using antagonist 8-NH3-cADPR. Both C122K and L149V mutants were able to 
internalize upon treatment with 8-NH3-cADPR. No effect of 8-NH3-cADPR on CHO Tet-
off cells transfected with W162G mutant. The surface membrane fluorescence remained. 
Scale bar = 20 µm. 
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3.11 Cell Surface Biotinylation of Wild-type CD38 and W162G mutant  
 Membrane proteins were labeled with sulpho-NHS-biotin and streptavidin-
agarose (Sigma) was used to absorb biotinylated proteins which were eluted from the 
agarose. This will determine if CD38 was able to internalize from the surface membrane 
to the internal compartments upon â-NAD+ treated. We have affinity purified the untreated 
(absence of â-NAD+ ) cell lysates (Figure 3.14A) and the internalized CD38 from â-NAD+ 
treated wild-type CD38 and W162G mutant (Figure 3.14B).  
 The flowthrough and the eluates from the purified samples which correspond 
to surface and internalized, biotinylated proteins, respectively, were resolved on SDS-
PAGE under reducing conditions. Results are as shown in (Figure 3.14A and 3.14B). 74-
kDa band corresponding to CD38-GFP fusion was seen on the immunoblot. As for the 
untreated cells (absence of â-NAD+), CD38-GFP fusion protein is only present in the 
flowthrough of wild-type CD38 and W162G mutant (Figure 3.14A, Lane 1 and 3). These 
results indicated in the absence of â-NAD+, all biotin- labeled CD38-GFP remained on the 
surface after incubation and was debiotinylated during the subsequent treatment with 
GSH. This resulted in the failure to bind to streptavidin matrix and thus no band was 
observed in the eluates of both untreated wild-type CD38-GFP and W162G mutant cells. 
The fusion protein band was present in the flowthrough (Figure 3.14B, lane 1) and the 
eluate (Figure 3.14B, lane 2) of wild-type CD38-GFP cells treated with â-NAD+. As for 
W162G mutant transfected cells, they failed to internalize upon â-NAD+ treatment and 
thus remained on the surface membrane. Therefore, we can only observe fusion protein in 
the flowthrough (Figure 3.14B, lane 3) of these cell lysates but not in the eluate of the 
W162G mutant transfected cells treated with â-NAD+ (Figure 3.14B, lane 4).  
 











Figure 3.14 (A) Western blot analysis of untreated (absence â-NAD+) of wild-type 
CD38-GFP and W162G mutant transfected cells using a biotin/streptavidin based 
method. Immunoblot analysis of CD38-GFP fusion protein (74-kDa) purified from CHO 
Tet-off cells. The flowthrough and eluate of untreated cells were concentrated with 
centricon-30 and 30µg of each sample was subjected to 10% SDS-PAGE under reducing 
conditions. The membrane proteins were harvested and analyzed by Western blot as 
described under Material and Methods Lanes 1 and 2 show the protein fraction of 
flowthrough and eluate of untreated wild-type CD38-GFP transfected cells, respectively. 
Lanes 3 and 4 show the protein fraction of flowthrough and eluate of untreated W162G 





















Figure 3.14 (B) Western blot analysis of â-NAD+-treated internalized wild-type 
CD38-GFP and W162G mutant transfected cells using a biotin/streptavidin based 
method. Internalized CD38-GFP fusion protein (74-kDa) was purified from CHO Tet-off 
cells by a biotin/streptavidin based method, as described in Material and Methods. The 
flowthrough and eluate of â-NAD+-treated cells were concentrated with centricon-30 and 
30µg of each sample was subjected to 10% SDS-PAGE under reducing conditions. The 
membrane proteins were harvested and analyzed by Western blot as described under 
Material and Methods. Lanes 1 and 2 show the protein fraction of flowthrough and eluate 
of â-NAD+-treated wild-type CD38-GFP transfected cells, respectively. Lanes 3 and 4 
show the protein fraction of flowthrough and eluate of â-NAD+-treated W162G mutant 
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 In the â-NAD+ - treated cells, a fraction of the biotinylated- labeled wild-type 
CD38-GFP escaped de-biotinylation and translocated to the intracellular compartment. 
Upon lysis, this fraction of internalized CD38 was bound to the streptavidin matrix and 
appeared in the eluate of the â-NAD+ - treated cells. Therefore the cluster appears as a 
fusion band under reducing condition on the Western blot. The streptavidin eluate from 
the W162G mutant treated with â-NAD+ showed no visible band on the Western blot. This 
result suggests the importance of ADP-ribosyl cyclase which might play an important role 
in the internalization of CD38. CD38 internalization has been proposed as a mechanism 
by which the ectoenzyme produced intracellular cADPR which may assist in Ca2+ 
signaling. 
 The internalized CD38 purified by biotin/streptavidin was found to be active in 
terms of ADP-ribosyl cyclase and cADPR hydrolase activities. The respective internalized 
CD38 cyclase and hydrolase activities are shown in (Figure 3.15A and Figure 3.15B). As 
expected, the internalized wild-type CD38 exhibited both ADP-ribosyl cyclase and 
cADPR hydrolase activities, which did not vary significantly from the surface CD38. As 
seen in the same figure, W162G mutant was not able to internalize and thus no protein 
was pulled down by immobilized streptavidin. Taken together, our findings suggested that 














































Figure 3.15 (A) ADP-ribosyl cyclase and cADPR hydrolase activities of internalized 
molecule of wild-type CD38-GFP and W162G mutant purified from CHO Tet-off 
cells by a biotin/streptavidin based method. The membrane proteins were harvested and 
analyzed as described under Material and Methods. The ADP-ribosyl cyclase activities of 
both internalized both wild-type CD38-GFP and W162G mutant transfected cells were 
determined fluorometrically as the production of cGDPR from the substrate NGD+.  
 





































Figure 3.15 (B) ADP-ribosyl cyclase and cADPR hydrolase of internalized molecule 
of wild-type CD38-GFP and W162G mutant purified from CHO Tet-off cells by a 
biotin/streptavidin based method. The membrane proteins were harvested and analyzed 
as described under Material and Methods. The cADPR hydrolase of the wild-type CD38-
GFP and W162G mutant were measured with the use of cyclic IDP-ribose, which can be 
readily hydrolyzed by CD38 to indicate the hydrolase activity.  
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  The relationship between the ectocellular localization of the cADPR-
synthesizing CD38 and the intracellular site of Ca2+-mobilizing activity displayed by 
cADPR is a challenging topic in the areas of membrane biochemistry and signal 
transduction.  In this study, we have cloned and expressed the construct, pTRE2-CD38-
GFP in mammalian cells. GFP was chosen because its fluorescence is an intrinsic 
property of the protein, and does not require additional gene products. Besides, time and 
effort can be saved by not having to raise antibodies to localize CD38 in live cells. The 
GFP-tagged CD38 is labeled stoichiometrically, and may be used to follow 
internalization in live cells in real time. A similar work expressing CD38-GFP fusion 
protein in NIH-3T3 cell line has been reported previously (Adebanjo et al., 1999).   
 
 In addition, the conventional methodology used in the study of the cellular 
localization of CD38 has always been immunostaining. The use of antibodies, have 
several drawbacks such as artifacts introduced during the process of fixation and 
permeabilization. The ease with which GFP-tagged CD38 may be observed means 
significant timesaving over other methods. The GFP-tagged CD38 also enables studies 
involving ligand-dependent internalization in live cells in real time to be performed. 
However, at times, the presence of GFP may affect the integrity of the protein of interest. 
Therefore, the GDP-ribosyl cyclase enzyme assay was carried out to see if the GFP 
protein interfered with the catalytic activity of the ectoenzyme, CD38. The fusion protein 
was shown to have GDP-ribosyl cyclase activity (Figure 3.9 A). This suggests that the 
bulky GFP protein did not perturb the proper folding of CD38, as the gross misfolding 
may likely affect the catalytic property of CD38. The disadvantage of having CD38-GFP 
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fusion protein was that the fusion protein may not behave the same as the wild-type (non-
GFP) protein and may give incorrect localization results. Another problem faced when 
using GFP is that the intensity of the fluorescence is relatively low and sometimes 
requiring special filters to be viewed. Furthermore, care should be taken when assessing 
any results that incorporate GFP technology, so as to make sure that the proteins’ 
function and localization has not been compromised. Here, the presence of green 
fluorescence has indicated that GFP protein was properly folded and CD38 is functional.  
 
 Previously, it has been shown that Human lymphoid Namalwa B cells (a 
continuous B-cell line derived from Burkitt’s lymphoma) are constitutively expressing 
CD38+ as shown by immunofluorescence staining and assay of CD38 ectoenzyme 
activities. Incubation of these cells with either NAD+ or thiol compounds, e.g. GSH, was 
found to elicit extensive internalization in non-clathrin-coated vesicles, as shown by 
different experimental approaches including cytofluorimetric analyses, assays of total 
versus ectocellular CD38 enzyme activities, transient cell surface biotinylation 
experiments and cryoimmunoelectron microscopy (Zocchi et al., 1996).  
 
 The results of the site-directed mutagenesis presented in this study have also 
identified the importance of the catalytic domain of CD38 ligand-dependent for its 
internalization. The extracellular functional domain of CD38 catalyzes the synthesis of 
cADPR from NAD+. It is possible that internalization of CD38 may increase the 
synthesis of cADPR intracellularly, which in turn regulate intracellular Ca2+-induced Ca2+ 
release (CICR) mechanism in many cell types. Ligands- induced internalization of CD38 
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has been observed in a variety of cells (Zocchi et al., 1999) and was shown to associate 
with cADPR-dependent Ca2+ increases (Han et al., 2000). It is possible that such 
internalization mechanism may lead to an increase in the concentration of cADPR in the 
nucleus, which in turn can result in Ca2+ release via the nuclear ryanodine receptor 
(RyR). Previous studies have shown the presence of RyR in cardiac nuclear envelopes. 
(Guihard et al., 1997; Gyorke et al., 1993). Ca2+ mobilization in the nucleus is known to 
play an important role in nuclear events such as DNA replication and transcriptional 
activation. Therefore, ligand-dependent internalization might represent a means for 
switching on some intracellular functions of CD38. 
 
 Another system, which is similar to the ligand-enhanced endocytosis, is 
growth factor receptor (EGF receptor) signaling. The messages, which promote growth, 
come from outside the cell in the form of protein growth hormones. EGF binds to the 
surface of cells by attaching to EGF receptor. The complex of hormone and receptor is 
then carried inside the cell which induces further changes in the cytoplasmic domain of 
the transmembrane receptor (i.e. self phosphorylation, dimerization etc) resulting in the 
binding or clustering of components of the endocytotic complex.  
 
 Though the physiological ligand(s) for CD38 have yet to be identified, our 
findings have shown some ligands (â-NAD+, cADPR, 8-NH2-ADPR) were able to induce 
CD38 internalization. A proposed mechanism by which a topological problem of the 
ectocellular active site of CD38/intracellular localization of cADPR receptor could be 
overcome was suggested by the demonstration of a specific transporter system for NAD+   
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in plasma membrane and of CD38 itself as a cADPR transporter (Zocchi et al., 1999; 
Franco et al., 2001). The exact mechanism of how extracellularly produced cADPR from 
CD38 can be transported into the cells for signaling remains to be elucidated, but 
whatever the mechanism, the prime pre-requisite for internalization is the ADP-ribosyl 
cyclase activity of CD38, as shown in this study.  
 
 In this study, we have used GFP to follow internalization in live cells with 
wild-type CD38 and the constructed mutants. Previous studies have shown that double 
mutant of both Cys-119/Cys-201 of human CD38 has ADP-ribosyl cylcase that was equal 
to that of the wild-type, but is impaired in terms of internalization. From their data, these 
are indeed important sites for internalization and that a reducing agent has been identified 
to enhance CD38 internalization (Han et al., 2002). However, our data has shown that a 
single Cys-122 mutant (equivalent to human C119K) in rat CD38 was able to internalize 
upon ligands induction (Figure 3.12 B), despite the absence of cADPR hydrolase activity. 
Future work in this aspect should also include constructing another mutant, a rat 
equivalent of the human CD38 C119K/201E double mutant.  
  
 On the other hand, it has been shown that internalization of different 
transmembrane proteins which requires a di- leucine motif in the C-terminal domain 
(Aiken et al., 1994). A number of leucines (residues 124–145, 150–164, 208–229, and 
271–285) within the transmembrane and extracellular domains of CD38 can potentially 
form leucine zipper motifs, as proposed by Hurst et al., 1994. The dileucine motifs in the 
CD38 molecule is, however, not accessible to intracellular targeting because of its 
Chapter 4 Discussion & Conclusion  93 
extracellular location. We have mutated one of the leucine residues present in the di-
leucine motif in CD38 to study if such a mutant could still be internalize. Indeed, Leu-
149 mutant, lack of cADPR hydrolase activity, was still able to internalize (Figure 3.12 
C), despite the lack of only. Therefore, the two mutants have one common property – 
presence of ADP-ribosyl cyclase activity. Taken together, these data have shown that the 
presence of ADP-ribosyl cyclase was able to induce internalization, which will enable 
future studies of downstream processes.  
  
 Data on the Glu-229 mutation with no CD38 expression on the surface 
membrane (Figure 3.11 E) and blockage of ligand- induced internalization (data not 
shown) are consistent with the previous finding that Glu-226 residue is essentially 
important for all enzymatic activities of CD38. As seen in (Figure 3.11 E), Glu-229 
mutant was probably associated with the internal membranes, which appeared to be 
associated with the endoplasmic reticulum (ER). This mutant may be grossly mis-folded 
and could not exit the ER. Since CD38 was not expressed on the surface membrane, it 
has suggested the importance of the catalytic domain for signal transduction.  
 
 To further substantiate that the presence of ADP-ribosyl cyclase will mediate 
internalization of CD38, we have constructed another mutant (W162G), which has 
significantly reduced ADP-ribosyl cyclase activity, but its cADPR hydrolase remains 
intact. CD38-GFP expression of W162G was found to remain on the surface membrane 
but it was not able to internalize upon the use of different inducing agents (Figure 3.12 D, 
Figure 3.13 A, lane 3 and Figure 3.13 B, lane 3).  Although the exact mechanism of 
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ligand- induction for CD38 internalization is yet to be determined, from the above 
constructed mutants, the ADP-ribosyl cyclase activity of CD38 seems to be an important 
factor for ligand- induced internalization.  The brief time of exposure to the different 
ligands (2h) is sufficient to elicit the changes in subcellular localization as seen in this 
study. In this study, we are only interested in CD38 being internalized upon ligand-
induced. We were not clear which internal compartment CD38 and its mutants were 
localized after being induced. Further work can be carried out using double labeling 
experiments with early and late endosome markers, where it will be able to clearly 
suggest the exact re-localization of CD38 and its mutants. So far, no report has shown or 
addressed the nature of endocytic vesicles involved in ligand-dependent CD38 
internalization.    
 
 In conclusion, we have presented evidence that the ADP-ribosyl cyclase 
activity play an important role in ligand-induced CD38 internalization. It is worth noting 
that internalization of CD38 may also result in the import of ADP-ribosyl cyclases 
activity from the cell surface to internal membranes. We can postulate that once CD38 is 
internalized, it brings along the cADPR produced, it is possible through this the cADPR 
system may play an important role in Ca2+ mobilization. We can conclude from these 
results that the decreased in the green fluorescence on the plasma membrane upon 
treatment with the different internalizing agents is due to ligand-dependent internalization 
of CD38 in CHO Tet-off cells. This is consistent with the previous study which had 
shown that the internalized CD38 had similar catalytic activities as in normal surface 
CD38 (Natesavelalar and Chang, 1999). This suggests that the internalized CD38 can 
Chapter 4 Discussion & Conclusion  95 
catalyze the intracellular synthesis of cADPR if it has an access to the cytoplasmic pool 
of NAD+. Subsequently, the intracellular formed cADPR can also mobilize Ca2+ from 
intracellular stores. Figure 4.1 summarizes the properties of the mutants and their 
localization.  
 
 A more direct test for the regulated expression of CD38 was achieved by 
transfecting CHO cells with Tet-off expression construct containing full- length wild-type 
CD38 (Figure 3.8). The expression of CD38 can be activated by treating the transfected 
CHO cells with tetracycline. We have seen that removal of tetracycline has enabled 
expression of CD38 on surface membrane of CHO Tet-off cells and with different 
internalizing agents added after 12hr expression, CD38 was able to internalize and its 
expression was located around the perinuclear membrane. We have also confirmed the 
presence of tetracycline has no effect on the morphology of CHO cells.  
 
 With the use of tetracycline system, we hope to mimic physiological 
conditions of CD38 and unravel the precise mechanism of its internalization in further 
studies. Will CD38 follow the ubiquitous pathway of degradation or will it be recycled 
back to the cell surface for the same function to produce cADPR? Alternatively, it would 
be of interest if we can study the difference, if any, in down-modulation of the wild-type 
CD38 and the mutants. CD38 down-modulation by internalization might be, along with 
shedding, another regulatory element in both functions. Although the enzymatic function 
and the ability of signal transduction of CD38 have been extensively investigated, the  
 














Figure 4.1 Diagrammatic representation of enzymatic activities and localization of wild-
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link between these two activities still awaits elucidation. Previous studies have provided 
evidence that an adhesion molecule, CD31 (platelet endothelial adhesion molecule-1, 
PECAM-1) functions as a putative CD38 ligand (Deaglio et al.,1998). It would be of 
interest to study whether a recombinant CD31 can mediate internalization of CD38 
similar to that induced by â-NAD. 
 
 Further studies on the level of cADPR intracellularly as compared with the 
extracellular level may lead to a better understanding of exact mechanism of intracellular 
trafficking and CD38 internalization. Nevertheless, our data has indicated the major 
ADP-ribosyl cyclase action of CD38 is to enable internalization to occur. More research 
has to be done on the signaling pathways of the ectoenzyme, CD38. An effort to unravel 
the precise mechanism of CD38 internalization and the pathway of intracellular 
trafficking has to be made. An approach using immuno electron microscopy may be 
useful to provide information concerning the precise topology of CD38 in the nuclear 
membrane, as previous study has shown that CD38 was found to be on the nuclear 
membrane after internalization. A better understanding of all the mechanisms involved in 
regulating CD38 function may be useful for understanding the mechanisms involved in 
the regulation of Ca2+ homeostasis.  
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